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OBJECTIVES: 
 
To measure: 
 
1. The rate of compliance to oral hypoglycemic agents, 
 
2.  The level of physical activity and caloric intake and  
 
3. The level of glycemic control among diabetics managed in the periphery. 
 
4. To measure the association between each of these factors independently 
and in combination with glycemic controls. 
 
 
METHODS:  
 
A cross sectional study was done. One hundred participants were randomly 
selected for the study. All those above the age of thirty, being treated for diabetes 
mellitus type 2 in the doctor-run mobile clinic were eligible to participate in the 
study. Those on insulin therapy and those bedridden were not included. The 
following parameters were measured for each person:  
 
(a) Diet intake  
 
(b) Physical activity  
 
(c) Compliance to therapy  
 
(d) Glycated hemoglobin 
 
Correlation between these factors and glycemic control was measured. 
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RESULTS: 
 
Out of the 100 participants, 74% were female, and47% were from the upper 
middle class. Those who were taking 80% of the expected number of pills were 
classified as compliant and it was found that 50.5% of those prescribed metformin 
were compliant and 45.3% of those prescribed glibenclamide were compliant. 
 
The mean caloric intake per day was 1614.83 Kcals (95%CI 1494.6- 1735.1) 
 
Out of the 100 participants 39% had a sedentary lifestyle and 60% had moderately 
active lifestyle. 
 
The mean Hba1c was 7.3% and 48.8% had ideal glycemic control. The remaining  
25.6% had unsatisfactory control. 
 
No correlation was found between sedentary lifestyle and uncontrolled sugars. It was 
found that HbA1c significantly reduced with better adherence. 
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1. INTRODUCTION AND JUSTIFICATION 
 
 Diabetes mellitus has been recognized for long and in all ancient civilizations (1). 
The endeavour to understand and treat this condition is a long one. Numerous 
studies have been conducted to understand its etiopathogenesis, progression and 
treatment (1). The incidence of diabetes is increasing and the onset is at a younger 
age. Diabetes related complications are on the rise, thereby creating a large burden 
on the health care system (2). 
 With the current knowledge and understanding of the disease, prevention is not 
possible but early diagnosis and treatment is possible (3). If this is neglected we 
may have a large portion of our population suffering from complications 
associated with diabetes such as coronary heart disease, peripheral vascular 
disease and diabetic retinopathy which can result in severe debilitation.  
Treatment of this condition however has other challenges. The treatment of 
diabetes is lifelong and it involves the use of medication every day, changes in 
lifestyle in terms of diet, exercise patterns and with at least the one check up every 
quarter(4). These requirements will drastically change a persons‟ life. All these 
pharmacological and non-pharmacological methods target one end point – good 
glycemic control. Adequate glycemic control greatly depends on the patient‟s 
adherence to the treatment.  
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Many strategies have been studied to improve adherence. One such strategy is to 
educate the patient and make him/her an expert on diabetes (5). Teaching patients 
to use home blood glucose monitors and to adjust doses of insulin and oral 
hypoglycemic agents empowers them to control their sugars.  Interventions such 
as „education about diabetes, home visits, motivational interviewing‟ and 
„problem solving treatment‟ administered by public health nurses have been 
studied through randomized clinical trials (4). 
There are three possible approaches to control the problem of diabetes – firstly a 
community based intervention, secondly a clinic based intervention to target high 
risk patients and thirdly a combination of the two methods (6). 
The Community Health and Development (CHAD) programme initiated by the 
Community Health Department of the Christian Medical College, Vellore, India, 
has been providing integrated health and development services to the people of 
Kaniyambadi block with a population of around 108,000 in North Arcot district 
since 1975. The primary care component of the program involves a health care 
team consisting of health aides, public health nurses and doctors. Through a 
mobile clinic which visits every village once a month this team identifies people 
who need treatment for various medical problems including diabetes mellitus. 
This team, through their mobile clinic, conducts monthly health check-ups for all 
those diagnosed to have diabetes mellitus and prescribes the needed drugs at a 
subsidized rate depending on the affordability of the patients. The Department of 
Community Health also conducts regular health education programs in  every 
village and through street theatre and educates the community about the 
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symptoms of diabetes, the need for regular treatment, lifestyle changes required 
and complications of diabetes. 
Thus the CHAD programme aims at improving the glycemic control among 
diabetics by improving their knowledge about diabetes and by providing regular 
health care. This study aims to assess the glycemic control of diabetics who 
managed at the periphery and measure their compliance to treatment. The findings 
from this study will provide a better insight into the performance of the diabetes 
management component of the CHAD programme and would provide valuable 
inputs towards improving the existing diabetes management component thereby 
improving the quality of lives of diabetics who utilize the CHAD program as their 
primary source of health care in Kaniyambadi block. 
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2. AIMS AND OBJECTIVES 
 
Aim: 
To estimate the rate of compliance to the treatment of diabetes mellitus among 
individuals in the Kaniyambadi block, Vellore district in rural South India. 
Objectives 
 To measure the rate of compliance to oral hypoglycemic agents among patients with 
diabetesmellitus type 2, being treated at the monthly doctor run mobile clinics by the 
Department of Community Health, Christian Medical College in Kaniyambadi block of 
Vellore district. 
1.  To measure the level of compliance, physical activity and caloric intake among 
these patients. 
2.  To assess the level of glycemic control among diabetics managed at the periphery.  
3.  To measure the association between physical activity, diet and compliance with 
drugs independently and in combination with glycemic control.  
 
Hypothesis 
People with diabetes can achieve adequate glycemic control by being treated at 
the periphery through doctor –run mobile clinics. 
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3. LITERATURE REVIEW 
 
3.1 Diabetes Mellitus- An overview 
3.1.1 Definition: 
“The term diabetes mellitus describes a metabolic disorder of multiple etiologies 
characterized by chronic hyperglycemia with disturbances of carbohydrate, fat and protein 
metabolism resulting from defects in insulin secretion, insulin action, or both” (7). 
 
3.1.2 History of diabetes: 
 The earliest references to the disease mentioning the symptoms of polyuria and 
complications such as gangrene can be found in the ancient papyruses from the Egyptian 
civilization dating back to 1552 BC.   In 1500 BC Indian thinkers noticed that ants were 
attracted to the urine of people who had a certain condition.  The father of Indian 
medicine, Susruta, in his Samhita has described this condition as “madhumeha”(meaning 
excreting urine which has a taste of honey)(8). Traditional healers of every ancient 
civilization have described this condition. It was noted in very early years that there were 
two forms of this illness- one that affected children and one that was associated with 
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sedentary life. It was also noticed that children affected by this condition had a very poor 
prognosis, living only for around 6 months (8). 
 
Aretaeus of Cappadocia, a Greek physician, in the first century BC, coined the term 
„diabetes‟. The term originated from the Greek word diabainein which means „to siphon‟ 
(1). He also described the main symptoms of frequent urination, excessive thirst and 
increased appetite. He was not able to treat this disease successfully and summarized the 
life of a diabetic in these words- “short, disgusting and painful”. 
Over the centuries many modes of treatment have been tried with varying rates of success. 
The treatment of diabetes with insulin started in 1922 with the discovery of insulin and its 
role in the metabolism of blood glucose, thanks to the work done by Banting and Best (9). 
Over the years thereafter other pharmacological therapies were developed. Sulphonylureas 
were introduced in the 1940‟s and biguanides were re-introduced in the 1950‟s. 
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3.1.3 Glucose metabolism in a non- diabetic person: 
After a meal the plasma sugar levels rise and prevents the release of NEFA (Non 
esterified Fatty acids) from the adipose tissue. This results in a fall in the fatty acid 
oxidation and stimulation of insulin production. Insulin promotes the uptake of insulin 
into various tissues in the body. As glucose uptake occurs hepatic production of glucose is 
inhibited. Hepatic production of glucose in an ongoing process as the brain requires a 
constant supply of glucose (10). 
Figure 3.1: Glucose metabolism in the human body
 
Source: spectrum.diabetesjournal.com 
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3.1.4 Pathogenesis: 
Type 2 diabetes, which is also called adult onset diabetes or non-insulin dependent 
diabetes, is the result of a combination of many factors. This disease condition has a 
gradual onset and remains undiagnosed for the initial part of the disease process. Some of 
the important factors which have found to increase the risk of developing diabetes are: 
family history of diabetes, past history of gestational diabetes, obesity, hypertension, 
dyslipidemia and ethnicity. 
3.1.5 Diagnosis of Diabetes mellitus type 2: 
The classical symptoms of diabetes mellitus include polyuria, polyphagia and polydipsia. 
People with symptom suggestive of diabetes are advised to test their blood sugars and any 
one value exceeding the limits for blood sugars according the WHO classification is 
diagnosed to have diabetes. 
Table 3.1: WHO diagnostic criteria (values for the diagnosis of diabetes mellitus and 
other categories of hyperglycemia: 
 Fasting venous blood 
(plasma) 
2 hour post prandial 
venous blood(plasma) 
Diabetes mellitus >=126mg/dl >=200mg/dl 
Impaired fasting glycemia 111-125mg/dl <140mg/dl 
Impaired glucose tolerance <126mg/dl 140-200mg/dl 
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3.1.5 Classification of Diabetes Mellitus: 
Diabetes mellitus is classified based on its etiology.  The revised WHO Classification of 
Diabetes Mellitus was published in 1999 as follows (7): 
(1) TYPE 1:  
- Autoimmune 
- Idiopathic 
(2) TYPE 2  
- Insulin resistance with relative insulin deficiency or 
- Secretory defect with or without insulin resistance 
(3) OTHERS 
(a) Due to specific mutations resulting in increased genetic susceptibility 
- Genetic defects of beta cell function (Eg: Maturity Onset Diabetes of the Young) 
- Genetic defects in insulin action 
(b) Diabetes associated with other diseases and pathological conditions 
- Diseases of the exocrine pancreas  
 Fibrocalculouspancreatopathy 
 Pancreatitis 
 Trauma/ neoplasia 
- Endocrinopathies 
 Cushing‟s  
 Acromegaly 
- Drug induced 
- Infections  
 Congenital rubella 
 Cytomeglovirus 
- Other genetic syndromes 
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The current classification of diabetes is based on the etiology and is as follows (11): 
Figure 3.2: The current classification of Diabetes Mellitus 
 
Insulin deficient diabetes: 
Types 1a and 1b account for 5-20% of all diabetics. Type 1b is also called Fulminant/ 
African type of Diabetes.  
Type 1 diabetes mellitus: is characterized by beta cell destruction caused by an 
autoimmune process usually leading to absolute insulin deficiency (12). 
Type 2 diabetes mellitus: is the most common form of diabetes mellitus and many factors 
contribute to the development of this condition. It is characterized by a combination of 
inadequate insulin secretion and action (12). 
 
 
Diabetes 
mellitus 
Insulin 
deficient 
Immune 
mediated 
(Type 1a) 
Non immune 
mediated 
(Type 1b) 
Insulin 
deficient/ 
resistant 
Monogenic 
Polygenic 
(Type 2) 
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3.1.6 Treatment of diabetes: 
The Indian Council for Medical Research (ICMR) has laid down targets for the treatment 
of Diabetes mellitus. These targets are just guidelines. Ideally targets of therapy must be 
individualized. 
Tight control of sugars is recommended in individuals with end organ damage and control 
of sugars may be “relaxed” in elderly (13). 
Table 3.2: ICMR Guidelines for Management of Type 2 Diabetes- 2005 
 Ideal Satisfactory Unsatisfactory 
Fasting plasma sugars 80-110 111-125 >125 
2 hour post prandial sugars 120-140 140-180 >180 
HbA1c <7 % 7-8% >8% 
 
Diet in Type 2 Diabetes:   
It was in the year 1675 that Thomas Willis measured the sweetness of the urine and 
proposed that it originated from the blood. He was the first to advise a diet high in 
carbohydrates but low in calories.  
   Currently, diet restrictions are routinely advised to all individuals with diabetes mellitus 
and universally accepted as the first line of treatment. The diet usually advised to a 
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diabetic is a low caloric diet in which the carbohydrate content is 50%, the fats are 
restricted to <30% and one which has a high amount of dietary fibre. 
    Many studies have been done to study the benefits of this diet composition. One such 
study was done in Austria, on 35 obese diabetics, to determine the optimal diet to control 
sugars and lipids in patients with diabetes. They were all advised a diet of 1600 
kilocalories with different diet compositions. The study found that this moderate energy 
restriction resulted in weight loss and the decrease of blood sugars irrespective of the diet 
composition (14).A Cochrane systematic review of RCTs involving different diet 
intervention of more than 12 weeks duration was done and this showed no significant 
changes in weight or glycemic control on the long run. Also, none of the diets studied 
(low carbohydrate diet, low fat diet, usual care diet and low glycemic index diet) showed 
any extra benefits (15). 
Patients with diabetes are commonly advised a diet with high carbohydrate content and 
this is a matter of debate. On many occasions it has been proven that a high carbohydrate 
diet causes an increase in plasma insulin and triglycerides resulting in a rise of blood 
sugars in the post prandial period (16). Studies have also shown that when dietary fibre is 
combined with the high carbohydrate diet blood sugars are better controlled (7). The 
mechanism is not fully understood but it has been proposed that dietary fibre retards 
digestion and absorption (16). Based on this it has been proposed that all food with high 
fibre content will have low glycemic index and will help in glycemic control. 
An interventional study done in Japan  looking at the benefits of diet in glycemic control 
and prevention of nephropathy revealed that a moderate to low carbohydrate diet (38% 
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carbohydrate) resulted in  a significant reduction in body mass index, HbA1c,and in the 
excretion of urinary albumin (17). 
 A Cochrane systematic review of 36 randomized controlled trials studying low fat/high 
carbohydrate diets, high fat/low carbohydrate diets, low calorie (<1000 kilocalories per 
day) diets and very low calorie diets (<500 kilocalories per day ) revealed there was not 
enough evidence to support dietary restrictions in the management of diabetes mellitus 
type 2 (18). However it did show that regular exercise was found to be useful in achieving 
good glycemic control.  
Exercise in Type 2 Diabetes:  
Exercise has been found useful in the control of diabetes. High levels of free fatty acids in 
the plasma result in inhibition of the enzymes pyruvate dehydrogenase and 
phosphofructokinase and this results in reduction in the uptake of glucose. Exercise has 
been shown to be useful by decreasing the amount of circulating free fatty acids and thus 
improving glucose uptake.  Exercise has also been shown to improve insulin sensitivity of 
tissues (19). 
Studies done in south India have revealed that “sedentarism” - the adoption of sedentary 
behavior is on the rise, and this is contributing to the growing diabetic epidemic in the 
country (20).Weight reduction in obese patients has been found to be a useful in achieving 
good glycemic control (21). 
A Cochrane systematic review of 8 clinical trials involving 2241 participants randomized 
to exercise and diet and another 2509 to standard recommendations for individuals 
without diabetes revealed the following results. The risk of developing diabetes among the 
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individuals on exercise and diet was reduced by 37% when compared to the individuals 
who were neither on diet nor exercise. An improvement was seen in body weight, waist 
circumference and blood pressure. However no benefits were seen in terms of reduction of 
cardiovascular morbidity, all cause morbidity and quality of life. This systematic review 
concluded that diet and exercise in combination helped in reducing the risk of developing 
diabetes but the role of exercise alone in the prevention of diabetes needs further research 
(3). 
Oral Hypoglycemic Agents (OHAs):  
Many individuals diagnosed to have type 2 Diabetes will be unable to achieve adequate 
glycemic control with lifestyle modifications alone and will require oral hypoglycemic 
agents. Oral hypoglycemic agents are classified based on their mechanism of action (22). 
The commonly used oral hypoglycemic agents fall into 4groups:  
1. Sulphonylureas, which are secretagogues: (Example: glibenclamide, glipizide, 
glimepiride and Gliclazide) 
 
2. Biguanides (Example: Metformin), which reduce hepatic glucose production  
 
3. Thiazolidinediones(Example: Pioglitazone and Rosiglitazone), which have an 
insulin sensitizing action. 
 
4. Alpha glucosidase inhibitors (Example: Acarbose) which delays the digestion and 
absorption of carbohydrates from the intestine. 
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OHAs are initiated at low doses and the titrated upwards based on the glycemic control 
achieved (22). 
Each drug has its own profile of adverse effects. Decisions about long term therapy with 
OHAs should be taken after considering the tolerability and convenience. The first 3 
classes of oral hypoglycemic agents have been found to cause a 1-2% decrease in the 
HbA1c. Alpha glucosidase inhibitors have not been found to be as effective. 
 
Metformin: 
Many studies have been done to explore the benefits of metformin and to see if they go 
beyond good glycemic control. A systematic review of 29 trials including studies 
measuring outcomes such as mortality, morbidity, quality of life and glycemic control was 
done. These studies compared metformin versus sulphonylureas, placebos, diet, 
thiazolidinediones and insulin. It was found that a significant reduction in the risk of 
mortality and diabetic complications was found in obese patients on metformin when 
compared to those on placebo and diet. A moderate benefit was seen in terms of glycemic 
control, reduction of LDL and reduction of weight and BMI when compared to those on 
sulphonylureas(23). Some of the common side effects caused by metformin are 
gastrointestinal side effects such as gastritis and diarrhoea. Metformin Extended release 
(Metformin XR) is a preparation that requires less frequent dosing and is associated with 
fewer gastrointestinal side effects and better compliance (24). 
 
Sulphonylureas: 
 
Hypoglycemia is a side effect that is commonly seen among those being treated for 
diabetes mellitus. The greatest risk for hypoglycemia is among those using insulin 
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followed by those using sulphonylureas. Studies have shown that a hypoglycemic event 
was associated with s significant risk ofnon-compliance in the form of discontinuation of 
drug therapy. Patients with hypoglycemia also have been found to have a significantly 
higher expenditure on diabetes related health care (25). 
 
Thiazolidinediones: 
This is a group of oral hypoglycemic agents. Trials have shown that this group of OHA‟s 
is as effective as the others. However it has not been found to have any benefits in terms 
of preventing cardiovascular or peripheral vascular morbidity. Compared to other OHA‟s 
it was found to cause more pedal edema (26). 
 
3.1.7 Maintaining good glycemic control in diabetes:  
 
Role of Hemoglobin A1c in measuring Glycemic control: 
 
Hemoglobin A1c (HbA1c) was first discovered in 1958 and was described as a 
characteristic of diabetes in 1969.Also known as glycosylated hemoglobin, 
glycohemoglobin, hemoglobin A1c or hemoglobin A1, measurement of the HbA1c levels 
gives an average of the plasma sugars over the last 3 months. The advantage of this 
method is that the specimen can be collected at any time of the day irrespective when the 
patient has had his last meal (27). 
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Table 3.3: Average blood sugars in mg/dl that corresponds to HbA1c values: 
 
HbA1c Average blood sugars in mg/dl 
4 60 
5 90 
6 120 
7 150 
8 180 
9 210 
10 240 
11 270 
12 300 
13 330 
14 360 
 
 
HbA1c may be measured using the following analytical methods: 
- HPLC (high performance liquid chromatography) 
- Affinity chromatography, 
 
- Electrophoresis, 
 
- Immunoenzymatic and 
 
- Immunoturbidometric methods 
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The UK Prospective Diabetes Study concluded that lower blood sugars reduced the risk of 
microvascular complications. This was measured using a Bio-Rad Diamat analyser and 
the reference value used was 4.5-6.2% (28). 
 
Impact of good glycemic control: 
A longitudinal cohort study conducted by the Diabetes Control and Complications Trial 
Research Group, followed 1441 patients with IDDM for a period of 6.5 years has revealed 
that tight control of sugars decreased the risk of developing retinopathy, micro 
albuminuria and the risk of developing clinical neuropathy thus preventing  macro 
vascular and micro vascular complications and also resultedin a higher risk of 
hypoglycemia (29). Though this study was done on people with insulin dependent 
diabetes the authors have extrapolated these results to those with non-insulin dependent 
diabetes mellitus. 
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3.1.8 Complications of Diabetes Mellitus: 
The complications of diabetes can be classified as follows: 
Figure 3.3: Complications of Diabetes Mellitus 
 
Reference: (30) 
Diabetic ketoacidosis (DKA) is more commonly seen in those with type 1 diabetes. DKA 
is a clinical condition characterized by high sugars, presence of metabolic acidosis and 
high amount of total ketone bodies in the blood. This commonly occurs due to 
discontinuation of insulin. Factors linked to discontinuation of treatment include financial 
constraints, feeling unwell, depression, no access to insulin, alcohol and substance abuse 
(31). 
Diabetic 
complications 
Acute 
Diabetic 
Ketoacidosis 
Hypoglycemia 
Hyperosmolar 
Non Ketotic 
Coma 
Infections 
Chronic  
Microvascular 
Macrovascular 
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Hypoglycemia is a condition in which blood sugars fall to less than 60mg/dl. The 
symptoms may vary from dizziness and palpitation to loss of consciousness. In the USA 
studies have shown that the number of hospital visits due to hypoglycemia is 0.054 per 
patient per year. The greatest risk of developing hypoglycemia was seen in those who 
used insulin. The next group of people who were at a risk of developing hypoglycemia 
were those who used sulphonyureas. Those on biguanides and thiazolidinediones were not 
at an increased risk of hypoglycemia. The people who had experienced hypoglycemia 
were at a higher risk of discontinuing their medication. It was also found that they had a 
higher all cause expenditure and diabetes related expenditure than those who did not. 
They spent an extra US$5024 on overall health care and an extra US$3747 on the 
treatment of diabetes (25). 
Hyperosmolar non ketotic coma is more commonly seen inthose with type 2 diabetes 
mellitus. 
Infections such as respiratory (30) and periodontal infections (32) are more common 
among people with Diabetes. People with diabetes are more prone to have pneumcoccal 
pneumonia, cavitatory lesions in tuberculosis and periodontal disease. The link between 
periodontal disease and diabetes is a long one. It has been shown that treating periodontal 
disease also helps in glycemic control. Chronic hyperglycemia has been shown to result in 
angiopathy.  Endothelial cells which from the inner lining of blood vessels do not depend 
on insulin for glucose uptake. When blood sugars increase endothelial cells increase their 
amount of glucose uptake. Thisresults in an increase in the amount of surface 
glycoproteins they produce subsequently increasing the thickness of their basement 
membranes.  
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This results in weakening of the endothelial lining thus causing angiopathy (33). 
Micro-vascular complications include retinopathy, nephropathy and neuropathy. Macro-
vascular complications include cerebro-vascular accidents, myocardial infarction and 
peripheral vascular disease (26). 
     A study in the Netherlands was done to study predictors for micro and macro vascular 
complications in people with diabetes. In all 563 people from 5 different Dutch hospitals 
were studied. The mean age group among the study participants was 68 and the mean 
duration of diabetes among them was 13 years. They had a median HbA1c of 7.5%. This 
study found that age, duration of diabetes, renal function, gender, atrial fibrillation and 
skin auto fluorescence were independently associated with macrovascular complications 
(34). Autofluorescence is defined as the natural emission of light from biological 
structures.Skin autofluorescence measures the amount of advanced glycation end-
products, which increase in Diabetes mellitus (35). 
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3.2 Challenges Related To Diabetes And Its Treatment 
3.2.1 The Growing Epidemic:  
Several studies have been done around the world to estimate the global prevalence of 
diabetes mellitus. One such study published in 2010 used estimates from 91 different 
countries and predicted a prevalence of 7.7% by the year 2030;  an increase of 69% in 
developing countries and 20% in the developed countries (36). Though the problem of 
diabetes mellitus is increasing in all continents it is growing fastest in India (20). The 
number of Indians living with diabetes in the year 2000 was 32 million and the 
International Diabetes Federation estimates that this number will rise to 69.9 million by 
2025. 
The Chennai Urban Rural Epidemiology Study (CURES) 2004 found that the crude 
prevalence of diabetes was 15.5% among adults aged 20 years and above with an age 
standardized prevalence of 14.3%. The burden of the disease was equal among both 
genders. This study also studied the prevalence of diabetes related complications. They 
found that the prevalence of vascular complications among those with diabetes was as 
follows: diabetic retinopathy 17.6%, diabetic nephropathy 2.2% and the prevalence of 
microalbuminuria was 26.9% (2). 
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The Chennai Urban Population Study compared the prevalence of coronary artery disease 
among diabetics and non-diabetics and their findings were as follows: 
 Diabetics General population 
Coronary artery disease 21.4% 9.1% 
Peripheral vascular disease 6.3% 2.7% 
 
   Studies done in rural India too have documented an increase in the prevalence of 
diabetes. The rate of increase in diabetes is 2.02/1000 population per year. The rate of 
increase in the prevalence of diabetes among men was found to be 3.33/1000 population 
per year and was greater than that among rural women, 0.88/1000. It was also found that 
there is a larger prevalence of impaired glucose tolerance and impaired fasting glucose 
among south Indians as compared to north Indians (37). The increase in prevalence of 
diabetes is of great concern as 70% of those with diabetes die due to cardiovascular 
diseases (37). 
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3.2.2 Compliance to the Treatment of Diabetes: 
Compliance is an issue which has been growing in importance as it was realized that 
despite the health care providers‟ best efforts treatment objectives remained unmet due to 
non-compliance to therapy. Since the 1970‟s a lot of research has been done on this issue. 
Through many studies it was found that compliance to long term treatment was only 40-
50% and compliance to short term treatment was higher- 70-80%. Compliance to life-
style modifications (including diet and exercise) was only 20-30%. Non-compliance can 
occur due to many factors and in many ways (38). 
Types of non-compliance (38):  
Non-compliance to treatment is a problem that can present in different ways .After 
reviewing literature available to date Jin et al have compiled a list of different ways in 
which non-compliance can occur. 
Receiving a prescription but not filling it. 
1. Taking an incorrect dose 
2. Taking medication at the wrong times 
3. Increasing or decreasing the frequency of doses 
4. Stopping the treatment too soon 
5. Delaying in seeking healthcare 
6. Non-participation in clinic visits 
7. Failure to follow doctor‟s instructions 
8. “Drug holidays”, which means the patient stops the therapy for a while and then 
restarts the therapy. 
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9. “White-coat compliance”, which means patients are compliant to the medication 
regimen around the time of clinic appointments 
 Numerous factors have been found to affect compliance. “Hard Factors” are the 
quantifiable factors that affect compliance to therapy, such as, cost of treatment, 
therapy related adverse effects, accessibility to health care services and 
satisfaction to treatment. “Soft factors” include unquantifiable factors namely 
attitude towards treatment, motivation and beliefs (38). 
Table 3.4: Factors affecting compliance 
Category Factors 
Patient-centered 
factors 
Demographic Factors: Age, Ethnicity, Gender, Education, 
Marriage Status 
 
Psychosocial factors: Beliefs, Motivation,Attitude 
 
Patient-prescriber relationship 
 
Health literacy 
 
Patient knowledge 
 
Physical difficulties 
 
Tobacco Smoking or alcohol intake 
 
Forgetfulness 
 
History of good compliance 
Therapy-related 
factors 
Route of administration 
 
Treatment complexity 
 
Duration of the treatment period 
 
Medication side effects 
 
Degree of behavioral change required 
 
Taste of the medication 
 
Requirements for drug storage 
Healthcare system 
factors 
Lack of accessibility 
 
Long waiting time 
 
Difficulty in getting prescriptions filled 
 
Unhappy clinic visits 
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Social and economic 
factors 
Inability to take time off work 
 
Cost and Income 
 
Social support 
Disease factors Disease symptoms 
 
Severity of the disease 
 
Reference: (38) 
 Compliance and adherence to treatment has also been found to be affected by “diabetes 
fatalism.” Diabetes fatalism is defined as “a complex psychological cycle characterized by 
perceptions of despair, hopelessness and powerlessness.”(39). A study done in South 
Carolina, USA showed that there was a significant association between diabetes fatalism 
and poor compliance, poor knowledge of diabetes and poor adherence to lifestyle 
modification. Many institutions have looked into factors affecting compliance to the 
treatment of diabetes mellitus. One such hospital based study done in Saudi Arabia 
revealed a non compliance rate of 67.9% among their patients (40). Some of the risk 
factors were:  
(1) male sex (OR=1.9, 95%CI  1.32 -4.57) 
 
(2)  residing in an urban area, (OR=5.21, 95%CI 3.65- 8.22) 
  
(3)  being illiterate (OR= 5.27, 95%CI 4.63- 7.19) 
 
(4)  Non adherence to exercise (OR=5.55, 95%CI 4.26- 6.00 ) 
 
 
The Canary Islands is an area where the mortality associated with diabetes is unusually 
high. A study looking at compliance to treatment in this region revealed that 48% of the 
men and 28% of the women did not follow the treatment as advised. Seventy five 
percentage of the women were found to have sedentary lifestyles and 54% of them were 
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obese. Dietary intake was measured in this population and it was found that 95% of them 
consumed large amounts of saturated fats (41).  
 
         A study done in a tertiary care centre in Kolkata in 2011 showed a poor compliance 
rate in 67.8% of their patients. They did not find age, sex or presence of co morbid 
conditions to be a risk factor for non-compliance. They however did find that housewives 
were at a greater risk of non-compliance. Those who had petty businesses had a higher 
compliance rate. This difference was suggested to be due to financial dependence among 
housewives and financial independence among those who had their own businesses. There 
was a significantly higher rate of compliance among those who had a good knowledge of 
diabetes mellitus (42). 
 
3.2.3 The cost of treatment of diabetes: 
 An important aspect of diabetes is the occurrence of complications. Studies in 1998  
showed that the cost of treatment of diabetes increases in the presence of diabetes related 
complication.  A patient with diabetic foot may increase his expenditure on health care 
from Rs. 4510 per year to Rs. 7200 per year.  
   It has been found that the expenditure on health care increases once a person has 
diabetes and increases further if the person develops complications related to diabetes. A 
study done in UAE in 2010 brought to light the impact of diabetes on the direct costs of 
health care. An individual with diabetes spent US$1,605/- per year on health care which 
was 3.2 times greater than the per capita expenditure on health care among those without 
diabetes. Direct costs on health care increased 2.2 times among those with micro vascular 
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complications, 6.4 times among those with macro vascular complications and 9.4 times 
among those with micro and macro vascular complications. 
        Direct expenditure on hospitalization increased too. In those with micro vascular 
complications it increased by 3.7 times. Among those with macro vascular complications 
alone it was higher by 6.6 times and was five times higher among those with macro and 
micro- vascular complications (43). 
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3.3 Strategies to combat the problem of Diabetes 
3.3.1 Prevention of diabetes mellitus: 
 A Cochrane review of 8 trials studying the benefit of diet and exercise in preventing 
diabetes among those with impaired fasting glucose and impaired glucose tolerance 
showed that there was no conclusive evidence to show that either of these methods was 
useful in preventing diabetes mellitus type 2. They were not found to be useful in 
combination as well (3). 
3.3.2 Interventions to improve compliance to therapy: 
Non-compliance is a complicated problem seen in many people with chronic diseases. In 
the United States of America there is a large burden of non compliance and it amounts to 
a financial burden of 1 billion US dollars annually on the health care system.  Many 
interventions have been studied to improve compliance to treatment. A Cochrane review 
of all interventions revealed the following results. Some studies involved interventions to 
improve the compliance to medical advice and some interventions targeted both patients 
and health care providers.  
Interventions provided by nurses: 
One intervention studied by Mease et al was the impact of educational classes along with 
weekly nurse visits in the form of telemedicine consultation. The control group received 
conventional care. When the two groups were compared the intervention group was found 
to have significantly lower Hba1c (0.4%). However technological problems were faced as 
the trial was being conducted (4). 
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  Another trial studied the benefits of “motivational interviewing and “problem solving 
treatment”. In this trial the control arm received intense counseling sessions from nurses. 
Each participant received 6 individual sessions of 30 minutes each and 3 monthly booster 
sessions via telephone. The participants in the control arm received brochures on the 
treatment of diabetes. They measured change in the risk scores of type 2 diabetes and 
cardiovascular risk factors as the primary outcome. The secondary outcome measured was 
the cost effectiveness and change in lifestyle. At the end of the trial it was found that the 
intervention was not useful as the attendance to each of these sessions was low. 
 
 
Home Aid interventions:  
Another trial studied the impact of more intensive care. The participants in the 
intervention arm received mailed packets (including contact details of their physician, 
danger signs of diabetes and scheduled appointment dates) a booklet on the management 
of diabetes and regular home visits by health aides in the event of missed appointments. 
They were compared against a control group that received usual care. It was found that 
there was an average decrease of 10.1mg/dl in fasting blood sugars in the intervention 
group as opposed to an increase of 5.1mg/dl in the control group. Also, the interventional 
group had 12% more contacts with their doctors and visited the ophthalmologist more 
regularly (2). 
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Diabetes education intervention  
Various studies assessing the impact of diabetes education on the change in HbA1c 
showed no difference between control and intervention arms (4). 
Patient participation: 
Patient participation programmes were compared against regular consultations with the 
physician. The outcomes that were measured included HbA1c, cardiovascular events, 
LDL and blood pressure. It was found that there was a significant reduction in each of 
these parameters in both arms.  
Studies involving patients in goal setting have shown that though collaborative goal 
setting is not directly associated with better sugar control it is associated with better self 
efficacy (44). 
At the end of the review of 21 trials on interventions to improve compliance the authors 
concluded that none of the interventions were useful, however they also had no adverse 
effects. Also the need for more research on interventions to improve adherence is needed 
 
A complete package for diabetes care:  
Diabetes mellitus is associated with microvascular and macrovascular complications and 
all follow up programmes aim at glycemic control and prevention of complications. The 
Geisinger Health Plan (GHP) proposed a bundle management of diabetes including 9 
components. Studies showed that individuals receiving treatment by the GHP had lower 
risk of developing diabetes related complications (45). 
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Table 3.5: Components on the bundle management protocol of the Geisinger Health 
Plan 
HbA1c Should be measured every months 
Target HbA1c <7% 
LDL To be measured yearly 
Target LDL  <100mg% 
Blood pressure <130/80 
Urine protein testing To be done annually 
Influenza immunization To receive the vaccine every year 
Pneumococcal immunization To receive one dose before the age of 65 
and one dose after 
Smoking status Patient should have stopped smoking. 
Source: thehealthplan.com 
 
 
 
 
 
 
 
 
 
40 
 
3.4 National Programmes to control the problem of Diabetes Mellitus 
National Diabetes Control Programme: 
In view of the rising prevalence of diabetes among Indians the Government of India 
launched the National Diabetes Control Programme (NDCP) (46).This was initiated 
during the VII Five year plan as a pilot project in a few districts in Tamil Nadu, Karnataka 
and Jammu and Kashmir with the following objectives:  
1. Prevention of diabetes through identification of high risk subjects and 
earlyintervention in the form of health education 
2.  Early diagnosis of disease and appropriate treatment morbidity and 
mortality withreference to high risk group 
3.  Prevention of acute and chronic metabolic, cardiovascular, renal and 
ocular complication of the disease 
4.  Provision of equal opportunity for physical attainment and scholastic 
achievement for the diabetic patients 
5. Rehabilitation of those partially or totally handicapped diabetes people.  
However, due to lack of funds, this programme was not expanded. In 2004 the 
Integrated Disease Surveillance Programme (IDSP) was initiated. This was to 
focus on infectious disease and screening of non communicable diseases.  
Screening was done by assessing anthropometry, physical activity, measuring 
blood pressure, screening for use of tobacco and assessing nutrition However the 
IDSP focused only on screening individuals for the presence of high risk factors. 
There was no interventional component (47). 
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   In 2005 the National Rural Health Mission (NRHM, 2005-2012) was launched. 
It aimed at the prevention and control of communicable diseases and non 
communicable diseases. Its core strategy was “developing capacities for 
preventive health care at all levels for the promotion of healthy lifestyles and 
reduction I consumption of tobacco and alcohol” (47). 
   Under the 9
th
five year plan (2007-2012) another programme was started to 
control the problem of non communicable diseases. This is the National 
Programme for the Prevention and Control of Diabetes, Cardiovascular disease 
and Stroke. This too is being launched in a phased manner (47). 
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3.5 Terms And Definitions 
Compliance: Patients behavior in terms of taking medication, following diet or 
executing lifestyle changes coinciding with the health care provider‟s 
recommendation for health and medical advice. 
The question of “what is good compliance” is a never ending debate. But 
researchers have agreed that 80% to 120% compliance is good. In this study all 
those with more than 80% compliance to pills have been classified as compliant 
Overall compliance: In this study overall compliance was the highest rate of 
compliance to ay one drug.   
Adherence:The ability and willingness to abide by a prescribed therapeutic 
regime.       
Good glycemic control: As per ICMR guidelines, those with a HbA1c of less 
than 7 were classified as people with good glycemic control. 
Good Knowledge of prescription score: Those who scored more than or equal to 
7 in the knowledge of score questionnaire were considered to have good 
knowledge.  
Regular attendance: Those who had missed their last visit were classified as 
irregular and those who had gone for their last appointment were classified as 
regular. 
 
43 
 
4. METHODOLOGY 
 
4.1 The Study design: 
A community based cross sectional study 
4.2 The study area: 
 The study was conducted in the Kaniyambadi block of Vellore district, Tamil 
Nadu. This is a rural developmental block which consists of 82 villages and has a 
population of over 1.10 lakhs. (Source: 2010 Census by the Dept. of Community 
Health, CMC, Vellore). 
The health care facilities available in the area include 3 government primary 
health care centers, one government tertiary care hospital, multiple small private 
clinics and the health care provided through the CHAD (Community Health and 
Development) program of the Department of Community Health and the multi-
specialty hospital of CMC, Vellore.  
For the last 30 years, the CHAD program has been providing primary and 
secondary health care in the Kaniyambadi block through its peripheral team and a 
120 bedded secondary care base hospital. The peripheral health care team consists 
of 17 health aides, 5 public health nurses and 3 doctors. One health aid is assigned 
to a population of 5000 (3-4 villages) to carry out the following duties: registering 
births, deaths, marriages, newly pregnant women, eligible couples, identifying 
people who need medical attention and to provide basic health education. The 
44 
 
public health nurse is assigned to take care of a population of 20,000 and is 
trained to provide basic health care to pregnant women, post natal women, 
neonates, patients with diabetes and hypertension and to identify people who need 
special medical attention.   
4.3 The doctor –run clinic: 
Every village is visited by a doctor run clinic once a month. The team members 
include one MD Community Medicine post graduate student, one intern, one 
public health nurse one health aid and one driver. At each clinic all antenatal 
women, sick children and people with diabetes, hypertension and other chronic 
illnesses are seen and managed as per established protocols. 
     Patients suspected with diabetes mellitus are referred to the base hospital. 
Blood investigations are done at the base hospital and if the patient is confirmed 
to have diabetes the patient is provided with a chronic disease card on which the 
advised medications and the blood results are noted. Once a month this patient 
visits the doctor run clinic, with this chronic disease card, where he/she is 
examined and given drugs for a month. Once in 3 months is the diabetics are 
advised to visit the base hospital to have their blood sugars tested. Based on the 
results, the doe of the oral hypoglycemic agents is titrated. Patients with diabetes 
are also advised to have regular opthalmological examination for diabetic 
retinopathy once a year and to have a serum creatinine measured once a year. 
  The doctor- run clinic has many advantages. As the team runs the clinic in the 
village the patient has no travel expenses and incurs no loss of wages. He/she is 
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also able to see the doctor free of charge. The patients‟ socioeconomic status is 
evaluated by the health aide and the public health nurse and the cost for the 
investigations and treatment depend on the affordability of the patient.  
At the periphery, the drugs are dispensed by the public health nurse under the 
supervision of a doctor who instructs them on the frequency and dosage of the 
drugs. 
4.4 Study Participants: 
Inclusion criteria: 
Any permanent resident of Kaniyambadi block, who 
 (1) Has been diagnosed with type 2 diabetes at least one year before 
(2)  Is on treatment with OHAs and 
 (3) Is over the age of 30 years. 
 
Exclusion criteria: 
(1) Patients on insulin  
(2) Patients who are bedridden 
4.5 Sampling and sample size calculation: 
Prevalence of compliance was estimated to be 50% (38). 
N=  
N=     
Thus, sample size was calculated to be 100. 
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Selection of participants:  
All patients with diabetes are registered in the CHAD health information system 
(HIS). The first 57 patients were recruited from the routine monthly peripheral 
clinics and the remaining 43 were randomly recruited by using the list of diabetics 
available in the CHAD HIS. 
4.6 The questionnaire: 
A standardised back translated questionnaire was used to collect general 
demographic data. 
Parameters measured for each participant Method used 
Knowledge of prescription Standardised knowledge of prescription 
questionnaire 
Diet intake 24 hour diet recall 
Level of physical activity WHO Global Physical Activity Questionnaire 
Glycemic control  HbA1c 
Adherence to oral hypoglycaemic agent Pill count 
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4.6.1 Global physical Activity Questionnaire. 
 
This questionnaire was created because of the need to have a standardised method of 
measurement of exercise all across the world. It reliability and validity was measured by 
testing it in 9 different countries. It was compared against an accelerometer. The 
reliability was found to be good. Spearman‟s rho was 0.67 -0.81 and Kappa was 0.67- 
0.73. But the criterion validity was only 0.06 –0.35, similar to other tools (48). 
 
 
4.6.2 Methods of measuring drug compliance: 
 
There are various methods of measuring drug compliance. The direct measure includes 
blood tests to measure the serum level of the drug. Indirect measure include patient self-
reporting, pill counts, pharmacy dispensing records and electronic monitoring – which is 
considered the gold standard for measuring drug compliance. But the method chosen for 
each study must depend on the type of study done and the possible inferences that are to 
be made (49). 
 
 
   A study was conducted in Boston in 1999 to compare patient reporting; pharmacy 
reporting and pills count against electronic monitoring, which is considered the gold 
standard of measuring drug compliance. It was found that pill counts had a moderate 
agreement with the electronic monitoring. Patient reporting of adherence was found to be 
poor and a lot of misclassification was noticed. However patient‟s reporting of non-
adherence was reliable and valid (50). 
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    In settings with financial restriction the use of pill counts along with patient self 
reporting has been found to be as useful as electronic monitoring (51). Another study done 
among African-American smokers, to estimate the adherence to the drug Varenicline 
using three different methods- pill counts, self reporting and a visual analog scale revealed 
that estimating pill counts were the most valid technique with a sensitivity of 88% (95% 
CI = 75.0-95.0) and a specificity of 80% (95%CI = 30.0-99.0) as compared to the gold 
standard (plasma measurement of Varenicline)(52). 
 In this study, conducted in Kaniyambadi block, pill counts were for every 
participant by doing home visits. 
Every participant has a self retained chronic disease card on which the details of 
the last visit, clinical findings and treatment details are noted. The expected 
number of drugs was calculated using the information from the chronic disease 
card. The observed number of drugs was recorded by counting the actual number 
of pills that were with the patient.  Drugs bought from outside were also taken into 
account. Compliance was measured by calculating the percentage of pills that 
were consumed. A compliance rate of more than 80% was classified as „good 
compliance‟ for the study.  
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4.6.3 Haemoglobin A1c measurement: 
A sample of venous blood, measuring 2ml, was collected from every participant at 
the time of the interview and the sample was transported to the Clinical 
Biochemistry laboratory at the Christian Medical College, Vellore within 24 
hours. Haemoglobin A1c was measured using the HPLC method with the Bio-Rad 
Variant 2. 
4.6.4Assessing Dietary intake: 
Methods of measuring dietary intake: 
Dietary intake may be measured using various methods.  
1. 24 hour diet recall: in this method the participant is asked to list out all food items 
consumed over the last 24 hours 
2. Food frequency score: different food types are listed e.g. cereals, pulses, green 
leafy vegetables, nuts and oils, meat etc. The participant is asked how frequently in a 
week each of the food items is consumed: once a week, twice a week or every day. 
3. Weighment method: in this method the interviewer is to spend the entire day in the 
participants house and must measure the actual weight of the food consumed and take into 
account the wastage as well.  
In this study, the dietary intake was measured using the 24 hour diet recall 
method. Each participant was asked to list out all food items and beverages 
consumed over the last 24 hours with the quantity consumed. The measurements 
were made with spoons, cups and bowls which were already measured. If they had 
consumed a food items not listed in the National Institute of Nutrition (NIN, 
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Hyderabad) they were asked to list all the ingredients of the dish. A person who 
had consumed coffee or tea was asked to specify the amount of sugar in the 
beverage. All the listed food items were converted into kilocalories using 
guidelines published by NIN, Hyderabad. 
 
3.6.5 Knowledge of prescription score: 
Each participant was asked to identify their tablets and correctly state the dose and 
frequency in which it was to be taken. A person on only one drug would be asked 
3 questions and those on 2 and 3 drugs had to answer each of these questions for 
each drug they were taking. So each person had a different number of responses. 
Their scores were all converted into a score out of 10. And those with a score of 
more than or equal to seven were classified as people with good knowledge of 
prescription. 
 
3.6.6 Measuring the Socioeconomic status: 
The socioeconomic status of each participant was measured using the Modified 
Kuppusamy scale for 2012. The per capita income, educational status and their 
occupation was used to calculate the score and based on the Modified Kuppusamy 
scale they were classified into lower and middle class. 
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4.7 Data entry and analysis:  
All the data was entered using EpiData3.1. Data analysis was done using SPSS 
17.0. For each participant the caloric intake, level of physical activity, compliance 
rate and knowledge of prescription was calculated.  For the entire study 
population the prevalence of good glycemic control, the prevalence of sedentary 
lifestyle and the average caloric intake was calculated. The correlation between 
each of the individual factors (drug compliance, physical activity and caloric 
intake) and glycemic control was measured.  
 A multiple logistic regression was done to measure the independent impact of 
each of these variables on the glycemic control (HbA1c). 
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5. RESULTS 
 
5.1 Demographic description of the study population: 
The 100 participants were selected from 22 different villages. The size of the 
clusters varied from 1to 9. 
 
5.1.1 Sex distribution of the study subjects: 
Table 5.1 Distribution of participants according to sex 
Sex Frequency Percentage 
Male 26 26% 
Female 74 74% 
Total 100 100% 
 
Women formed the major portion of the study population, 74% of the total. 
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5.1.2 Age distribution of study subjects: 
 
Figure 5.1: Age distribution among the participants 
 
 
 
The age of the participants varied from 40 to 85.The mean age of participants was 
60.36 years with a standard deviation of 10.2 years. 
 
 
 
 
0%
5%
10%
15%
20%
25%
30%
35%
40-49 50-59 60-69 >=70
P
er
ce
n
ta
g
e 
o
f 
 p
eo
p
le
 
Age group in years 
N=100 
age distribution
33 
25 
28 
14 
54 
 
5.1.3 Occupation: 
 
Table 5.2: Distribution of occupations of the study subjects 
 
Occupation Frequency Percentage 
Unemployed 21 21% 
Housewife 24 45% 
Manual/Agricultural Labourer 19 19% 
Skilled Labourer 12 12% 
Petty Shop Owner/Cultivator 
Owner 
16 16% 
Salaried and pensioners 8 8% 
Total 100 100% 
 
 
A majority of the study participants were involved in household work. Nineteen 
percent were involved in either manual or agricultural labour and 21% of the 
study population was unemployed. 
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Figure 5.2 Gender-wise distribution of occupation 
 
Among the women 32.4% were involved in household work, 20.2% were 
involved in manual or agricultural labour and 22.9% of them were unemployed. 
Among the men 42.3% were either shop owners or cultivator owners. A larger 
proportion of men had salaried jobs or received pension (23.1%) when compared 
to women (2.7%). As compared to women fewer men were unemployed. 
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5.1.4 Socioeconomic status as measured by Modified Kuppusamy Scale:  
 
 
Figure 5.3: Distribution of socioeconomic status of participants 
 
 
 
 
 
Fifty five percentage of the participants were from the lower socioeconomic group 
and 45% from the middle socioeconomic group.  
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5.2 Lifestyle and behavior: 
 
Use of alcohol and tobacco: 
 
Table 5.3: Current use of alcohol/ tobacco 
Current Use Of 
Alcohol/tobacco 
Frequency Percentage 
Yes (use alcohol or 
tobacco) 
5 5% 
No (neither use alcohol 
nor tobacco) 
95 95% 
Total  100 100% 
 
 
Out of the 100 participants only 5 gave history of using tobacco or alcohol.  
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5.3 Medical History: 
5.3.1 Time since diagnosis of diabetes: 
The time duration since diagnosis was estimated for each participant and it varied 
from 1 to 20 years. The mean duration since diagnosis of diabetes was 5.46 years 
and the interquartile range was 2-7 years. 
 
Table 5.4: Mean number of years since the diagnosis of diabetes 
Age group in 
years 
Mean years since 
diagnosis of diabetes 
40-49 4.1 
50-59 4.5 
60-69 6.6 
>=70 5.76 
 
The above table shows that with increasing age, duration since diagnosis of 
diabetes is increasing which is expected in chronic diseases.  
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5.3.2 Co-Morbid Conditions present among participants: 
Out of the 100 participants 30% had no co morbid conditions, 50% had only one 
co morbid condition and the remaining 20% had 2 co morbid conditions. The 
most common co-morbid condition was hypertension. 
 
Figure 5.4: Types of co-morbid conditions  
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5.3.3 Drug combinations prescribed: 
 
Figure 5.5: Various Drug combinations prescribed to the participants 
 
 
 
 
Metformin was the most commonly used oral hypoglycemic agent and was used 
in combination with glibenclamide for 57% of the participants. 
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5.3.4 Number of pills per day 
 
Figure 5.6: Distribution of pill load per day among participants  
 
 
From each person‟s chronic disease card the number of drugs with their dosage 
and frequency was noted and the total number of pills the patient was advised to 
take per day was estimated   
Many of the patients had co morbid conditions and were on more than one drug. 
The pill load varied from 2 to 16 pills per day. The average number of pills 
prescribed to the patients was 8.024 per day. 
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5.3.5 Occurrence of adverse effects due to OHAs: 
Figure 5.7: Occurrence of side effects due to oral hypoglycemic agents 
 
 
 
Patients on treatment for diabetes experienced side effects due to the oral 
hypoglycemic agents. Out of the 100 participants 57 experienced no side effects. 
Out of the remaining 43 participants 35 had one side effect and 8 had 2 side 
effects. 
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Types of side effects due to OHAs: 
 
Figure 5.8: Types of side effects experienced 
 
 
The most common side effect was gastritis.. Out of the 43 people who had 
experienced side effects, 58.1% had gastritis, 11.6% had diarrhoea and 20.9% had 
dizziness. Some of the “other” side effects experienced were fatigue, constipation, 
headache and feeling of tension 
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5.3.6 Patient incurred cost for medication: 
 
Figure 5.9: Patient incurred cost per month 
 
 
 
The amount on money spent per month on drugs varied. The above graph shows 
that 15% of the participants received treatment that was free of cost. An average 
of Rs. 34.34 was spent on medication. 
  This difference in the amount spent on medication is because each patient‟s 
socioeconomic status is assessed and they are expected to pay only what they can 
afford.  
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5.4 Knowledge of prescription score: 
Figure 5.10: Distribution of knowledge of prescription score 
 
 
 
Each participant was asked to identify their OHA‟s and state the dosage and 
frequency at which the drug was prescribed by their doctor. For every correct 
answer the person was awarded a score of one and these scores were converted to 
a scale of 10. A large proportion of the subjects (72%) were able to correctly 
identify their tablets and state the prescribed dose and frequency.  
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5.5 Lifestyle:  
5.5.1 Diet intake: 
Figure 5.11: Distribution of daily total calorie intake  
 
Each participant‟s diet intake was measured using a 24 hour diet recall and 
converted into calories using standards prescribed by the National Institute of 
Nutrition, Hyderabad. 
The daily caloric intake ranged from 704.25 to 5419.30 Kilocalories. 
The mean caloric intake per day was 1614.83 Kcal with a 95% Confidence 
Interval of 1494.6 -1735.1 Kcals and standard deviation of 601.2 Kilocalories. 
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Figure 5.11 shows the distribution of calorie intake among the men and women. 
Out of the 26 men, 50% of them consumed less than 1800 kcals per day and out of 
the 74 women, 84.6% of them consumed less than 1800 kcals per day. 
 
Figure 5.12: Distribution of caloric intake among men and women. 
 
Out of the female participants 52.8% consumed less than 1500kcal per day and 
another 31.8% of them consumed 1500-1800kcal per day.  
Out of the 26 men 15.4% were consuming less than 1500kcal per day, 34.6% 
consumed 1500-1800 kcal and 11.5% consumed 1800-2000 kcals.  
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5.5.2 Physical Activity: 
 
Table 5.5: Percentage of people involved in each type of activity 
 
Type of activity % of People involved % of people not involved 
Vigorous intense activity 10 90 
Moderately intense activity 17 83 
Walking/ using cycle for 
transport 
86 14 
Recreational activity 1 99 
 
The above table shows that 10 people out of 100 were involved in vigorous 
intense activities,like carrying heavy weights and climbing stairs or inclined 
slopes, which cause increase in heart rate or respiratory rate. 
Seventeen out of 100 were involved in moderate intense activities,like carrying 
small weights, which cause increase in heart rate or respiratory rate.  
Overall 25 people out of 100 were involved in either vigorous or moderate intense 
activity. 
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Out of 100 participants 84 either walked or used a bicycle for transport for at least 
10 minutes in a day. 
Only 1 person was involved in moderately vigorous recreational activities. 
Each person was questioned on involvement in each type of physical activity 
(vigorous and moderate intense activity at work and during recreation) and the 
amount of time spent relining or resting. The number of days and minutes spent 
per day in each of these activities was also measured. As per the GPAQ protocol 
these responses were all clubbed together and reclassified. So each person,based 
on the overall time spent on each type of physical activity, was classified as a 
person with a sedentary lifestyle, moderately active lifestyle or a highly active 
lifestyle. 
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Figure 5.13: Levels of overall physical activity 
 
 
Only one male participant fell in the category of high activity. Thirty nine percent 
of the participants were leading a sedentary lifestyle. 
 
To validate this tool 10% of the sample population was interviewed by the public 
health nurses. 
The results are given below: 
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Table 5.6: Observed agreement among the observers while using the Global 
physical activity questionnaire 
Findings of the principle investigator 
 Low activity Moderate 
activity 
High activity 
low activity 2 3 0 
Moderate 
activity 
0 1 0 
High activity 0 4 0 
 
Table5.7: Expected agreement among the observers 
Findings of the principle investigator 
 Low activity Moderate 
activity 
High 
activity 
low activity 2 3 0 
Moderate 
activity 
0 1 0 
High activity 0 4 0 
Findings of the 
public health nurses 
Findings of the 
public health nurses 
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Observed agreement = 30% 
Expected agreement= 18% 
Kappa statistic= (observed agreement- expected agreement)/ (100- expected 
agreement) 
Kappa= 14.6%  
This concludes that there was poor agreement between observers while using this 
tool. 
5.6 Glycemic control as assessed by HbA1c 
Figure 5.14: Distribution of HbA1c levels among the study participants 
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The values of HbA1c ranged from 5.2 to a maximum of 12.1%.. The mean HbA1c 
was 7.3 % with a 95% confidence interval of 7.024-7.576. According to the ICMR 
guidelines of 2005, 48.8% of the study population had ideal glycemic control, 
25.6% had satisfactory glycemic control and 25.6% had unsatisfactory control. 
5.7 Compliance rates to OHAs: 
Table 5.8: Compliance to OHAs  
Compliance 
rate 
Metformin Glibenclamide 
<50% 28.9% 17% 
50-79% 34.0% 17% 
>=80% 37.1% 66% 
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5.7 Correlations And Associations 
5.7.1 Correlation between HbA1c and Daily total calorie intake: 
 
 
 
The Pearson‟s correlation co-efficient was -0.023 with a significance value (2 
tailed) of 0.821 and this finding was not statistically significant. 
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5.7.2 Correlation between HbA1c and compliance to drugs 
All participants were classified into the following groups: 
 compliant to 2 drugs (n=12),  
 compliant to 1 drug  (n=52) and 
 not compliant to any drug (n=36) 
The mean HbA1c was calculated for each of these groups: 
 
Figure 5.15:  Mean HbA1c versus compliance to OHAs 
 
 
Figure5.15 shows that those who are noncompliant to 2 drugs have the best 
glycemic control. Those with poor glycemic control are commonly advised 2 
drugs. Unless they take these tablets continuously for a period of time their sugars 
will not be controlled. This factor is not portrayed through this graph. 
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Figure 5.16: Correlation between HbA1c and adherence to glibenclamide 
 
The Pearson‟s correlation co-efficient was -0.168 suggesting that as adherence 
increases HbA1c decreases. However, this finding was not statistically significant 
as indicated by the significance value of 0.192.  
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Figure 5.17: Correlation between HbA1c and adherence to metformin  
 
 
 
 
 
 
 
1.  2.  
adherence rate 
to metformin glycatedhb 
adherence rate to 
metformin 
Pearson Correlation 1 -.264
**
 
Sig. (2-tailed)  .009 
N 97 97 
glycatedhb Pearson Correlation -.264
**
 1 
Sig. (2-tailed) .009  
N 97 100 
**. Correlation is significant at the 0.01 level (2-tailed). 
The correlation co-efficient was 0.264 which shows a 26.4% correlation between 
adherence to metformin and HbA1c and this was statistically significant. 
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Figure 5.18 Correlation between HbA1c and Overall adherence to OHAs. 
 
 
 
Overall adherence was calculated for each person by calculating the maximum 
adherence to any one pill. The Pearson‟s correlation co-efficient was -0.248 with a 
2 tailed significance value of 0.013. This means that there is a 24.8% correlation 
between overall adherences and HbA1c and this correlation is significant. 
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Figure: 5.18: Correlation between HbA1c and number of years since 
diagnosis: 
 
The Pearsons‟ correlation coefficient for this was 0.144. This means there is a 
14% correlation between glycated hemoglobin and years since diagnosis; however 
this finding was not statistically significant with a p value of 0.154. 
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5.7.3 Association between physical activity and glycemic control 
Based on the level of physical activity the participants were divided into 2 
categories: those who were sedentary and those who had moderate or high level of 
physical activity. The mean HbA1c of each of these groups were calculated and 
compared. 
 
Table 5.8: Group Statistics mean HbA1c versus level of physical 
activity 
 
 
sedentary N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Glycatedh
b 
sedentary 39 7.238 1.2671 .2029 
mod/high 
level 
61 7.361 1.4697 .1882 
 
To measure if this observed difference between the 2 groups was significant an 
independent sample t-test was done. 
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Table 5.9:  Independent samples t-test 
 Levene‟s test for 
equality of 
variances 
t- test for Equality of means 
 
F significance t df Significance 
(2 tailed) 
Mean 
difference 
Std. Error 
of 
difference 
Equal 
variances  
assumed 
0.375 0.542 -0.427 98 0.670 -0.122 0.286 
 
Table 5.10: Results of t-test comparing physical activity and HbA1c 
 Sedentary 
lifestyle 
Moderate/ high 
level of activity 
SE (95% CI) p 
value 
 mean SD  mean SD 
HbA1c 7.2% 1.26 7.3% 1.46 0.28(-0.068-0.044) 0.67 
 
The standard error of difference between the 2 means was not significant. This 
means that there was no significant association between physical activity and 
glycemic control. 
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 5.7.9 Glycemic Control among both genders: 
 
Table 5.11: sex * controlled sugars Cross tabulation 
   controlled sugars 
Total 
   
High sugars Controlled sugars 
  
Male 
Count 10 16 26 
Expected Count 12.2 13.8 26.0 
% within sex 38.5% 61.5% 100.0% 
female Count 37 37 74 
Expected Count 34.8 39.2 74.0 
% within sex 50.0% 50.0% 100.0% 
Total Count 47 53 100 
Expected Count 47.0 53.0 100.0 
% within sex 47.0% 53.0% 100.0% 
 
This two by two table shows that 38.5% of the male participants had poorly 
controlled sugars and 50% of the female participants had poorly controlled sugars 
(defined as HbA1c>=7%) in the study. 
A chi square test was done to measure the difference between the two proportions 
revealed a Chi square value was 1.028 and p value was 0.311. This means that sex 
is not associated with poor glycemic control. 
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5.7.10 Level of knowledge of prescription and glycemic control: 
 
Table 5.12 Level of knowledge of prescription * controlled sugars Cross tabulation 
   controlled sugars 
Total 3.  4.   High sugars 
Controlled 
sugars 
Level of 
knowledge 
Poor knowledge Count 15 13 28 
Expected Count 13.2 14.8 28.0 
% within level of 
knowledge 
53.6% 46.4% 100.0% 
Good 
knowledge 
Count 32 40 72 
Expected Count 33.8 38.2 72.0 
% within level of 
knowledge 
44.4% 55.6% 100.0% 
Total Count 47 53 100 
Expected Count 47.0 53.0 100.0 
% within level of 
knowledge 
47.0% 53.0% 100.0% 
 
This table shows that 53.3% of those with poor knowledge of their prescription 
had high blood sugars and 44.4% of those with good knowledge of their 
prescription had poorly controlled sugars. The Chi square test was done to test the 
significance of this difference. The Chi square value was 0.674 and the p value 
was 0.412. This means that the level of knowledge of the prescription is not 
associated with Glycemic control. 
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5.7.11 Socioeconomic score versus glycemic control: 
 
Table 5.13 SES group * controlled sugars Crosstabulation 
   controlled sugars 
Total 
   
high sugars controlled sugars 
SES group low Count 29 26 55 
Expected Count 25.9 29.2 55.0 
% within SES group 52.7% 47.3% 100.0% 
middle Count 18 27 45 
Expected Count 21.2 23.9 45.0 
% within SES group 40.0% 60.0% 100.0% 
Total Count 47 53 100 
Expected Count 47.0 53.0 100.0 
% within SES group 47.0% 53.0% 100.0% 
 
This table shows that 52.7% of those in the lower socioeconomic status group had 
poorly controlled sugars as opposed to 40.0% in the high socioeconomic group. 
The chi square test was done and the Chi square value was 1.609 with a p value of 
0.205. This means that the socioeconomic status of the person is not associated 
with poor glycemic control. 
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5.7.12 Occurrence of side effects versus glycemic control: 
 
Table 5.14 Experienced side effects * controlled sugars Cross tabulation 
   Controlled Sugars 
Total 
   
High Sugars 
Controlled 
Sugars 
Experienced Side 
Effects 
Yes Count 22 21 43 
Expected Count 20.2 22.8 43.0 
% within experienced side 
effects 
51.2% 48.8% 100.0% 
No Count 25 32 57 
Expected Count 26.8 30.2 57.0 
% within experienced side 
effects 
43.9% 56.1% 100.0% 
Total Count 47 53 100 
Expected Count 47.0 53.0 100.0 
% within experienced side 
effects 
47.0% 53.0% 100.0% 
 
This table shows that 51.2% f those who have experienced side effects and 43.9% 
of those who have no side effects have high sugars. The chi square test was done 
to see if this difference was significant. The Chi square value was 0.525 and the p 
value was 0.469. This means that the occurrence of side effects is not associated 
with poor glycemic control. 
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5.7.13 Physical activity versus glycemic control: 
 
Table 5.15 Sedentary * Controlled Sugars Cross tabulation 
   Controlled Sugars 
Total 
   
High Sugars 
Controlled 
Sugars 
Level of 
physical 
activity 
Sedentary 
Lifestyle 
Count 19 20 39 
Expected Count 18.3 20.7 39.0 
% within sedentary 48.7% 51.3% 100.0% 
moderate/high 
level of activity 
Count 28 33 61 
Expected Count 28.7 32.3 61.0 
% within sedentary 45.9% 54.1% 100.0% 
Total Count 47 53 100 
Expected Count 47.0 53.0 100.0 
% within sedentary 47.0% 53.0% 100.0% 
 
This table shows that 48.7% of those who lead sedentary lives and 45.9% of those 
who have moderate or high level of physical activity have poorly controlled 
sugars. The Chi square value was 0.076 and the p value was 0.783. This means 
that the level of physical activity is not associated with glycemic control. 
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5.7.14 Regular attendance versus glycemic control: 
Table 5.16 Regular attendance * Controlled Sugars Cross tabulation 
   Controlled sugars 
Total 
   
High sugars 
Controlled 
sugars 
Regular attendance Yes Count 36 51 87 
Expected Count 40.9 46.1 87.0 
% within regular 
attendance 
41.4% 58.6% 100.0% 
No Count 11 2 13 
Expected Count 6.1 6.9 13.0 
% within regular 
attendance 
84.6% 15.4% 100.0% 
Total Count 47 53 100 
Expected Count 47.0 53.0 100.0 
% within regular 
attendance 
47.0% 53.0% 100.0% 
 
In the CHAD run Mobile clinic drugs are prescribed for only one month at a 
time.For every patient the each visit is documented in the patient retained chronic 
disease card. Those who had missed their last clinic were classified as „irregular‟ 
and those who had not missed the previous clinic were classified as „regular‟. 
When the glycemic control of these two groups was compared, it was found that 
there was a significant association between clinic attendance and glycemic 
control. The Chi square value was 8.488 and the p value was 0.004. The  Fisher‟s 
exact test was 0.006  (2- tailed significance).People who attended the mobile 
clinic regularly were having 7.8 times higher odds of having controlled blood 
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sugars as compared to those who did not attend regularly. (OR = 7.8, 95% CI 1.6 
to 37.3). 
Summary of the univariate analysis : 
 
No. Risk factor Proportion 
of subjects 
with poor 
sugar 
control 
Chi square 
value 
p value 
1. Malegender 38.5% 1.028 0.311 
2.  Poor Knowledge of 
prescription score 
56.3% 0.674 0.412 
3. Low SES 52.7% 1.609 0.205 
4. Occurrence of Side 
effects 
51.2% 0.525 0.49 
5. Sedentary Physical 
activity 
48.7% 0.076 0.783 
6. Regular attendance at 
the mobile clinic 
41.4% 8.488 0.004 
 
5.8 Multiple Linear Regression 
Association between selected exposure variables and the main outcome variable 
namely glycemic control as measured by Hba1c was carried out using multiple 
linear regression. The independent variables chosen were gender, level of 
knowledge regarding the drugs prescribed, SES, physical activity, overall 
adherence to OHAs and years since diagnosis of the disease. 
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 Unstandardized coefficient B p value 
Constant 7.119  
Gender (Female) 0.613 0.050 
Level of knowledge of 
prescription (<70%) 
0.206 0.496 
SES (Low) 0.365 0.173 
Level of physical activity 
(Sedentary) 
-0.311 0.270 
Overall adherence  -0.013 0.002* 
Years since diagnosis 0.073 0.027* 
 
This linear regression analysis shows that after adjusting for other factors, overall 
adherence and years since diagnosis of diabetes is associated with glycemic 
control.  
    For every 1% increase in adherence there is a 0.01% decrease in HbA1c and for 
every year that passes after the diagnosis of diabetes there is an increase in the 
HbA1c by 0.07%. 
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6. DISCUSSION 
 
This is a cross sectional study which was designed to estimate the compliance rate 
to treatment of diabetes mellitus, the level of glycemic control, average caloric 
intake and level of physical activity and among patients attending the mobile 
clinic run by CHAD program of the Department of Community Health, CMC, 
Vellore. 
6.1 Socio-demographic profile:  
The study population consisted mostly of women. The timing of the mobile clinics 
is between 9 am and 5 pm and this could be one of the possible reasons for more 
women attending them at the villages, while the men tend to go outside for work. 
A majority of the participants were above the age of 60 and had been on treatment 
for diabetes for an average of 6 years. Fifty five percentage of the participants 
belonged to the low socioeconomic group and 45%were from the middle 
socioeconomic group. 
  Out of the 100 participants 30 had no co morbid conditions, 50 had at least one 
co-morbid condition and 20 had 2 co-morbid conditions.  Hypertension was the 
most common co morbid condition. 
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A study done in Kolkata in 2010 showed a similar demographic profile with 61% 
of their population being women and 61.07% of their population belonging to the 
45-65 year age group (54). 
6.2 Glycemic control: 
 This study assessed glycemic control by measuring HbA1c for all participants. 
HbA1c represents the average blood sugar levels of an individual over the last 3 
months. So the glycemic control measured in the study is for a period of 3 months 
only.   Using the ICMR set guidelines, 50% of the patients had „ideal‟ blood 
sugars (HbA1c <7%) and 24% had very poor control of blood sugars (HbA1c  
>8%). Poorly controlled sugars have been found to be associated with poor 
cardiovascular outcomes and these 24% need to be further evaluated (28).  When 
compared to some of the other studies done in India these results are comparable 
(53). Other Indian studies have shown a short term glycemic control of 37.7% and 
a long term glycemic control in only in 24% of patients (42). Studies done in 
Pakistan and Thailand also have shown lower rates of glycemic control 31.4% and 
26.3% (53). Thus the problem of diabetes and maintaining good glycemic control 
is a challenge in most countries around the world.   
 The glycemic control in the Kaniyambadi population seems to better than that 
found in other settings. Individual factors that affect glycemic control are 
discussed below in order to possibly explore this difference. 
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. 6.3 Caloric intake: 
The calorie intake varied from 750 kcal per day to 2800 kcal per day. In this study 
caloric intake was measured by a 24 hour diet recall. As the body mass index was 
not measured, the ideal calorie requirements could not be estimated and hence the 
calorie excess or deficit could not be studied. However a rough estimate can be 
made. Out of the 100 participants 75% had a calorie intake of less than 1800. A 
Cochrane review of randomized controlled trials have shown that diet restriction 
cause a reduction in glycated hemoglobin but there insufficient studies to show 
the benefit in terms of the reduction in the risk of developing micro and macro-
vascular complication (54). 
6.4 Level of physical activity: 
    This study was done in a rural area where agriculture is the main source of 
income. In this study, 60% of the participants were involved in either moderate or 
high levels of physical activity on a regular basis. This finding is similar to the 
findings seen among diabetics attending a tertiary care center in Kolkata, where 
the prevalence of sedentary lifestyle is around 37.4% (42). 
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6.5 Compliance to drugs:    
Pill counts were done at home for all 100 participants and it was found that 52% 
of participantsshowed an adherence of >80% to at least 1 drug.Studies from India 
have shown different levels of compliance varying from 11.3% to 33.2% (42). 
Some studies have shown that housewives are at a higher risk of non-compliance 
for financial reasons as they are not economically independent (42). In 
Kaniyambadi block, we see that economic status of the family is not a risk factor 
for poor glycemic control and the main reason for this could be that the treatment 
is subsidized depending on the affordability of the individuals. 
But compliance does not depend only on financial status and is a combination of 
many other factors. In Kaniyambadi block the compliance may be higher because 
the mobile clinic visits the village regularly thus improving the individual‟s access 
to health care. This more available and accessible form of health care may be the 
contributing factor to the better level of glycemic control measured in this study. 
6.6 Risk factors for poor glycemic control: 
In this study, the various risk factors studied were compliance to medication, level 
of physical activity, socioeconomic status, gender, knowledge of prescription, 
occurrence of side effects, regularity of attendance at the mobile clinicand total 
calorie intake. Overall compliance to medication and regular attendance at the 
mobile clinic showed a statistically significant association with good glycemic 
control. 
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After adjusting for the presence of other factors, a multivariate  linear regression 
analysis revealed that overall adherence to prescribed treatment and duration since 
onset of diabetes were significantly associated with glycemic control.We found 
that with improving overall adherence to OHAs, the HbA1c levels tend to 
decrease. We also noticed that as time since diagnosis of the diabetes increased 
the HbA1c values tend to rise. This is possible as diabetes is a condition in which 
the functioning of the beta cells of the pancreas progressively deteriorates with 
time (55). 
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7. LIMITATIONS. 
1. The study used the technique of pill counting to measure compliance to 
treatment. Although the method is valid, it had its own limitations in terms of 
inadequate documentation in the patient retained chronic disease cards, lost or 
misplaced drugs and drug sharing between family members. 
2. Physical activity was measured using the Global Physical Activity 
questionnaire. There are possibilities of random misclassification depending on 
the comprehension levels of the subjects and their responses. 
3. As each person‟s body mass index was not estimated the impact of this 
important variable on the glycemic control could not be assessed. 
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8. SUMMARY AND CONCLUSIONS 
 
1. Compliance rate to drug therapy among patients with Diabetes mellitus in 
Kaniyambadi block , being treated in the mobile clinics is as follows: 
 Compliance to metformin: 49 out of the 97 prescribed were compliant 
(50.5%) 
 Compliance to glibenclamide: 29 out of the 64 prescribed glibenclamide 
were compliant (45.3%) 
 Percentage of people who had compliance rates of more than 100% (those 
who were taking more tablets than advised) was 24% 
2. Level of physical activity among the patients with diabetes: 
 High level of physical activity = 1% 
 Moderate level of physical activity = 60% 
 Low level of physical activity = 39% 
3. The average nutritional intake among this population was 1614.83 Kcals 
(95% CI = 1494.572 -1735.1 Kcal) 
4. Percentage of people with well controlled sugars(HbA1c <7%) was 53%, 
(95% CI = 43.2% to 62.78%) 
5. Percentage of people with a HbA1c of  less than 6.5%  was 37% 
6.  No correlation was found between HbA1c and nutritional intake  
(r= -0.023) 
7. No significant association was found between sedentary lifestyle and 
uncontrolled sugars. 
97 
 
8. Those who have missed a clinic and have irregular attendance to the 
mobile clinic are at a higher risk of having poorly controlled sugars. 
9. Through linear regression analysis it was found that HbA1c significantly 
reduced with better adherence. 
10. The risk of poorly controlled sugars increases with time since diagnosis. 
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9. RECOMMENDATIONS 
 
1. The compliance rate to medication and glycemic control among the 
patients visiting the doctor-run clinic is comparable with studies done at hospital 
settings. However better follow up of those who miss clinics may be needed as 
they are at a higher risk of having uncontrolled sugars. 
2. The mobile clinic is visited by fewer men and this needs to be looked into 
given that the rate of increase of diabetes among the male population in rural areas 
is higher than that of women. 
3. Involving the patients in setting targets for glycemic control may help in 
achieving better glycemic control. 
4. Thirty nine percent of the population is not exercising sufficiently. More 
emphasis needs to be given on increasing the levels of physical activity in the 
ongoing diabetes management program. 
5. There are many advantages of a doctor-run clinic but one major advantage 
is that care is subsidized based on the socioeconomic status of each individual.  
This is a clear message that chronic illnesses are a financial burden and people 
require financial assistance in the treatment of these illnesses. 
6. Diet advice needs to be given clearly to patients with diabetes.  
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Annexure 1 : 
Information and consent form :Tamil version 
jfty; gotk; 
 
ehd; kUj;Jtuhfgzpg[hpa[k; rhl; kUj;Jtkidapy; eP';fs; rh;f;fiu 
neha;f;fhfrpfpr;irvLj;Jf;bfhz;oUf;fpwPh;fs;vd;gijmwpe;Js;ns
d;/ 
j';fisnghd;wnehahspfs; ve;jmstpw;Frpfpr;irKiwnahL 
xj;JiHj;JxU';fpize;Jnghfpwhh;fs; vd;gJbjhlh;ghdXh; 
Ma;itr;bra;acs;nsd;/ ehd; c';fsplk; c';fSilaczt[g; 
gHf;f';fs;. cly;ntiygS. kUe;Jcl;bfhs;Sjy; 
bjhlh;ghfrpynfs;tpfisnfl;ngd;/ 
mnjhLxUrpynehahspfs; vt;tst[ mst[ czt[ 
cl;bfhs;Sfpwhh;fs;vd;gJgw;wpbjhpe;Jbfhs;st[k; 
mDkjpnjitg;gLfpwJ/ Ma;tpy;g';FbgWk; 
vy;yhkf;fsplkpUe;Jk; rpwpjst[ ,uj;jk; vLj;J ,uj;jj;jpy; 
rh;f;fiuapd; mst[ fle;jZd;Wkhj';fspy; vt;tst[ ,Ue;jJvd;W 
fz;lwpat[k; ,uj;j&PnkhFnshgpdpy; rh;f;fiuZyf;TWcs;sjhvd 
fz;lwpat[k; njitg;gLfpwJ/ ,e;jMa;tpy; eP';fs; g';Fbgw;why; 
vdf;Fkpft[k; cjtpahf ,Uf;Fk;/ eP';fs; ,e;jMa;tpy; g';F 
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bgwhtpl;lhYk; rhl; kUj;Jtkidapy; fpilf;Fk; 
kUj;Jtnritfisbjhlh;e;Jgad;gLj;jyhk;/ eP';fs; ,e;jMa;tpy; 
g';Fbgw;why; ,uj;jg;ghpnrhjidKot[ 
c';fSf;Fbjhpag;gLj;jg;gLk;/ 
 
xg;g[jy; gotk; 
 
ehd; (bgah;) (fzth; bgah;) 
,e;jMa;itg;gw;wpaKGikahdjfty;fismwp;e;Jf; bfhz;nld;/ 
kw;Wk; ,ejMa;tpy; g';Fbfhs;svd;Dila KG rk;kj;jijj; 
bjhptpj;Jf; bfhs;fpnwd;/ 
 
xg;g[jy; mspg;gthpd; bgah; 
 
ifbaGj;J ? ,lJbgUtpuy; nuif 
 
Ma;thsh; ifbahg;gk; 
 
njjp 
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nfs;tpfs; 
rh;f;fiuneha; tifIIcs;sth;fs; cl;bfhs;Sk; 
khj;jpiufs; 
bjhlh;ghdMa;t[ 
 
1/ bgah; 
 
2/ taJ 
 
3/ nehahspapd; kUj;Jtkid ? Ma;t[ vz; 
 
4/ bjhHpy;| 
 
5/ fy;tpepiy| 
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6. Modified Kuppusamy Scale : 
 
 Highest in Family Score 
bjhHpy;  
 
 
fy;tpepiy  
 
 
khjFLk;gtUkhdk;  
 
 
 
7/ rh;f;iuneha; fz;Lgpoj;jgpd; MFk; tU;l';fs; 
 
8/ rh;f;fiuneha; jtpuntWVnjDk; RftPdk; ,Ue;jhy; 
mtw;iwthpirg;gLj;Jf| 
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9/ kJ mUe;Jk; gHf;fk; cs;sth;| Mk; ?,y;iy 
 
10/ Mk; vd;why;. mst[ kw;Wk; vt;tst[ 
ehl;fSf;FxUKiwFog;gPh;fs;+ 
 
11/ g[ifapiygHf;fk; cs;sth;| Mk; ?,y;iy 
 
12/ Mk; vd;why;. mst[kw;Wk; 
vj;jidKiwcgnahfpg;gPh;fs; 
 
12/ xUehisf;Fvj;jidkhj;jpiurhg;gpLfpwPh;fs;+ 
 
14/ xUkhjj;jpw;Fkhj;jpiuf;fMFk; bryt[ vt;tst[+ 
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15. Current Prescription   Cost of Prescription 
Drug Dose Frequency 
Metformin   
Daonil   
Pioglitazone   
 
 
16/ rh;f;fiuneha; vjph;g;g[ khj;jpiugw;wpamwpitbjhpe;J 
bfhs;tjw;fhdnfs;tpfs; 
a) / c';fSilakUj;Jtuhy; c';fSf;Fghpe;Jiuf;fg;gl;l 
khj;jpiuapd; bgah; vd;d+ 
khj;jpiu 1 - fpspbgd;fpsikL 
khj;jpiu 2 - bkl;ghh;kpd; 
khj;jpiu 3 - ignahfpspl;lnrhd; 
 
b)/xt;bthUKiwa[k;vj;jidkhj;jpiucl;bfhs;sntz;Lk; 
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khj;jpiu m - fpspbgd;fpsikL 
- xt;bthUKiwa[k; xUkhj;jpiu 
- xt;bthUKiwa[k; 2 khj;jpiu 
- xt;bthUKiwa[k; 11?2  khj;jpiu 
 
khj;jpiu M - bkl;ghh;kpd 
- xt;bthUKiwa[k; xUkhj;jpiu 
- xt;bthUKiwa[k; 11?2  khj;jpiu 
- xt;bthUKiwa[k; 2 khj;jpiu 
 
khj;jpiu , - ignahfpspl;lnrhd 
- xt;bthUKiwa[k; xUkhj;jpiu 
- xt;bthUKiwa[k; 2 khj;jpiu 
- xt;bthUKiwa[k 3 khj;jpiu 
c/ xUehisf;Fvj;jidKiweP';fs; khj;jpiucl;bfhs;s 
ntz;Lk; 
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khj;jpiu m - fpspbgd;fpsikL 
- xUehspyxUKiw; 
- xUehspy; ,uz;LKiw 
- xUehspy; Zd;WKiw 
khj;jpiu M - bkl;ghh;kpd 
- xUehspyxUKiw; 
- xUehspy; ,uz;LKiw 
- xUehspy; Zd;WKiw 
 
17/ Date of last visit 
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18. khj;jpiuvz;zpf;if 
Drug Observed Expected 
Metformin   
Daonil   
Pioglitazone   
 
 
eP';fs; rhl; kUj;JtkidapypUe;J th';fpa 
khj;jpiufisjtph;j;JntWahhplkpUe;jhtJkhj;jpiufis
gfph;e;Jbfhs;fpwPh;fsh+  Mk; vd;why;. vj;jid+ 
20/ c;';fSf;FVnjDk; gpd;tpist[ ? 
gf;ftpist[Vw;gl;Ls;sjh+ Mk; ? ,y;iy 
 
21/Mk; vd;why; eP';fs; mDgtpj;;;j gf;f 
tpist[fisg;gw;wp TW';fs; 
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22/ 24 kzpneuk; cz;zczitg;gw;wp TW';fs; 
 
Meals Food Quantity Calorie 
Breakfast    
Lunch    
Dinner    
snacks    
 
 
23/ cly; ntiy 
 
1/ c';fSilantiykpft[k; fodkhdJk;. ntiygS 
mjpfkhdjhdt[k; c';fSila ,UjaJog;g[k; RthrKk; 
mjpfkhf;Fk;gocs;sjh+ 
(vLj;Jf;fhl;lhfmjpfkhdvila[s;sbghUisj; J}f;Fjy;. 
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njhz;Ljy;. tPLfl;Lk; ntiy) ,e;jmwpFwpbjhlh;e;J 10 
epkpl';fSf;fhtJcs;sjh+    Mk; ? ,y;iy 
 
2/ bghJthfxUthuj;jpy; vj;jidehl;fs; 
nkw;Twpafodkhdntiyfisbra;tPh;fs;+ (vz;zpf;if 
1.2.3.4.5.6.7ehl;fs;) 
 
3/ xUehspy; kpft[k; fodkhdntiyiavt;tst[ neuk; 
bra;tPh;fs;+ 
 
4/ eP';fs; rhjhuzkhfntiybra;a[k;nghJ 
c';fSf;FVw;gLfpd;wRthrj;jpy; my;yJ ,jaJog;gpy; 
VnjDk; khw;wk; Vw;gLfpd;wjh+ (ck/ 
Fiwe;jvila[s;sbghUl;fis J}f;Fk;nghJbjhlh;r;rpahf 
10 epkpl';fSf;FZr;Rth';Fjy;)    
 Mk; ?,y;iy 
 
5/ xUthuj;jpy; bghJthfruhrhpahdntiyg;; 
gScs;sntiyiavj;jidehl;fs; bra;tPh;fs;+        (   
ehl;fs;) 
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6/ xUehisf;Fvj;jidkzpneuk; eP';fs; 
fodkhdntiybra;fPwPh;fs;+         (neuk; epkpl';fspy ;) 
 
7/ eP';fs; bghJthfxU ,lj;jpw;Fbrd;WjpUk;gFiwe;jJ 
10epkplj;jpw;fhtJirf;fps; Xl;LtPh;fsh+ 
my;yJelg;gPh;fsh+                 (Mk; ? ,y;iy) 
 
8/ Mk; vd;why;. xUthuj;jpy; bghJthfvj;jidehl;fs; 
Fiwe;jJgj;Jepkpl';fs; elj;jy; (my;yJ) irf;fps; 
Xl;LtPh;fs;+ (  ehl;fs;) 
9/ v';fhtJ bry;tjw;fhf bghJthfxUehisf;F 
vj;jidKiwele;J (my;yJ) irf;fps; Xl;obry;tPh;fs;+  
( kzpepkp;l';fs;) 
10/ eP';fs; Rthrk; kw;Wk; ,Ujaj;Jog;igmjpfg;gLj;Jk; 
kpft[k; fodkhdtpisahl;L. cly; 
fl;Lf;nfhg;g[f;fhdbray;fs; 
my;yJbghGJnghf;fhdbray;fs; 
(vLj;Jf;fhl;lhfXLjy;. fhy;ge;JtpisahLjy; ) 
Fiwe;jJ 10 epkpl';fSf;Fbra;tPh;fsh                                                               
(Mk; ? ,y;iy) 
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11/ xUthuj;jpy; vj;jidehl;fs; fodkhdtpisahl;L. 
cly; 
fl;Lf;nfhg;g[f;fhdgapw;rpmy;yJbghGJnghf;Ff;fhdbra
y;fspy; <LgLtPh;fs;                                                 
( ehl;fs;) 
 
12/ xUehspy; vj;jidkzpneuk; fodkhdtpisahl;L. 
cly; 
fl;Lf;nfhg;g[f;fhdgapw;rpmy;yJbghGJnghf;Ff;fhdbra
y;fspy; <LgLtPh;fs;                                             
( kzpepkp;l';fs;) 
 
13/ eP';fs; ruhrhpahfntiygSt[s;stpisahl;L 
clw;fl;Lf;nfhg;g[f;fhd bray; 
my;yJbghGJnghf;fhdbray;fs; Fiwe;jJ 10 
epkpl';fshtJbra;a[k;nghJ ,Ujaj;Jog;g[k; RthrKk; 
mjpfkhFkh+ (vLj;Jfhl;lhfntfkhfelj;jy;. irf;fps; 
Xl;Ljy;. ePe;Jjy;. ifge;JtpisahLjy; )                       
(Mk; ? ,y;iy) 
 
14/ ruhrhpahdntiygSt[s;stpisahl;L.  
clw;fl;Lf;nfhg;g[f;fhd bray; 
119 
 
my;yJbghGJnghf;fhdbray;fs; xUthuj;jpy; 
vj;jidehl;fs; bra;tPh;fs;+ ( ehl;fs;) 
 
15/ ruhrhpahdntiygSt[s;stpisahl;L. 
clw;fl;Lf;nfhg;g[f;fhd bray; 
my;yJbghGJnghf;fhdbray;fs; xUehspy; vt;tst[ 
neuk; ;bra;tPh;fs;+           ( kzp?epkp;l';fs;) 
 
16/ bghJthfxUehspy; vt;tst[ neuk; cl;fhUtjw;Fk; 
rha;e;J ,Ue;JXa;t[ vLf;ft[k; bryt[ bra;tPh;fs;         ( 
kzp?epkp;l';fs;) 
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Annexure 2  
Information and consent form with questionnaire: English version 
Informed consent 
Study on rate of compliance among patients on 
treatment for diabetes in CHAD mobile clinic. 
I understand that you have been taking treatment for 
diabetes mellitus from CHAD hospital, where I work as a 
doctor. I am conducting a study to see how patients like you 
are coping with the treatment. 
 I will be asking a few questions related to your dietary 
intake, routine physical activity and drug compliance.  I will 
need a few patients to permit me to weigh the amount of 
food they eat regularly.  I will be collecting blood from all 
participants to measure HbA1c, a measure of their sugar 
control over the last 3 months. 
 I will be grateful if you are willing to participate in this study. 
If you participate, you will not be paid any money or 
medicines as compensation and you will have to sign on this 
document. If you are not willing to participate in this study 
you can still continue to use the services that CHAD hospital 
provides. If you choose to participate in this study your 
results will be maintained confidential and the results of 
your blood tests will be revealed only to you. 
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I, (name)………………………., (s/o or w/o)…………………………... 
have understood  the information on this study and  give my 
consent to participate in this study. 
Name of participant: 
Study number          :  
 
Signature or thumb impression:                                  date: 
 
 
Signature of investigator:                                            date: 
 
 
Signature of witness:                                                   date: 
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Questionnaire  
Study on rate of compliance among men on 
treatment for diabetes in CHAD mobile clinic 
1. Name                                                            : 
2. Age                                                                : 
3. Study number                                              : 
4. Village number                                            : 
5. No. of years since diagnosis of diabetes : 
6. List of co-morbid conditions                      : 
7. Use of alcohol                                              : (y/n) 
If yes, specify the amount used per week: 
8.  Use of tobacco                                             : (y/n) 
If yes, specify pack years: 
9.  Number of pills per day (including all drugs) : 
10. Actual Cost of the prescription: 
11.  Money spent per month on drugs: 
12. SES (Modified Kuppusamy score): 
Education   
Occupation   
Monthly family 
income 
  
 
 
13. knowledge of prescription: 
From the medical record of the diabetic patient, the family 
physician’s prescription must be identified. Check (√) the 
corresponding box if the statement corresponds to the information 
written in the medical record of a diabetic patient. 
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14. Medication prescribed A:  Glibenclamide dosage: 
     1 tablet at each intake 
     2 tablets at each intake 
15. Glibenclamide dosage frequency: 
     Medication once a day: 
    Medication twice a day: 
     Medication three times a day: 
16. Medication prescribed B:  Metformin dosage: 
    1 tablet at each intake: 
     2 tablets at each intake: 
17. Metformin dosage frequency: 
     Medication once a day: 
    Medication twice a day: 
     Medication three times a day: 
18.  Medication prescribed C : Pioglitazone dosage 
                                             1 tablet at each intake 
                                             2 tablets at each intake 
                                             3 tablets at each intake 
19.  Pioglitazone dosage frequency: 
                                                Once a day                                                  
                                                Twice a day                                                    
                                                Three times a day                                      
 
20.With the following three questions we wish to know how you take 
the medication prescribed by your family physician at the last 
medical visit. If the patient´s answer corresponds with the 
information listed in the last section check (√) the corresponding box 
of the statement, otherwise place an (x). If the medication is not 
prescribed, leave the box blank. 
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KQ. 1. What is the name of the diabetes medication prescribed 
by your family physician? 
Medication A:  Glibenclamide*: 
Medication B:  Metformin:* 
Medication C:      Pioglitazone*                                                                 
 
KQ. 2. How many tablets a day do you have to consume at each 
intake? 
Medication A:  Glibenclamide: 
   1 tablet at each intake: 
   2 tablets at each intake: 
Medication B:  Metformin: 
   1 tablet at each intake: 
   2 tablets at each intake: 
Medication C:      Pioglitazone: 
                               1 tablet at each intake:                                              
                               2 tablets at each intake: 
                               3 tablets at each intake: 
KQ. 3. How many times a day do you have to take your 
medication? 
Medication A:  Glibenclamide: 
   Once a day: 
   Twice a day: 
   Three times a day: 
Medication B:  Metformin: 
   Once a day: 
   Twice a day: 
   Three times a day: 
Medication C:  Pioglitazone:  
                           Once a day: 
                           Twice a day: 
                            Three times a day: 
21. Pill count: 
Name of drug Expected number Observed 
Metformin   
Glibenclamide   
Pioglitazone    
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22. No. of pills acquired from other sources during the month: 
23. List some of the reasons for non adherence: 
       Side effects                          : (Y/N) 
       Cost of drugs                       : (Y/N) 
       Frequent travelling             : (Y/N) 
       Forgetfulness                       : (Y/N) 
       They are not needed          : (Y/N) 
       Any other reasons (specify): 
 
 
 
 
 
         24.   24 hour diet recall: 
           Total caloric intake: 
Meal Food items Calories 
Breakfast   
Lunch   
dinner   
snacks   
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Physical activity:  ( WHO STEPS Questionnaire) 
 
25.Does your work involve vigorous-intensity activity that  causes 
large increases in breathing or heart rate like for at least 10 minutes 
continuously? (yes/no) 
 
26. In a typical week, on how many days do you do  vigorous-
intensity activities as part of your work? (Number of days) 
 
27 How much time do you spend doing vigorous-intensity  activities 
at work on a typical day? (Hours : minutes) 
 
 28.   Does your work involve moderate-intensity activity, that causes 
small increases in breathing or heart rate such as brisk walking for at 
least 10 minutes continuously? 
 
29. In a typical week, on how many days do you do moderate-
intensity activities as part of your work? 
  Number of day’s ___ 
 
30. How much time do you spend doing moderate-intensity 
activities at work on a typical day? 
    Hours: minutes ( ……..:……) 
 
31. Do you walk or use a bicycle (pedal cycle) for at least 10 minutes 
continuously to get to and from places? (y/n) 
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32. In a typical week, on how many days do you walk or bicycle for at 
least 10 minutes continuously to get to places? ___________(number 
of days) 
 
33. How much time do you spend walking or bicycling for travel on 
a typical day? 
Hours : minutes _____: _____ 
 
 
34.Do you do any vigorous-intensity sports, fitness or recreational 
(leisure) activities that cause large increases in breathing or heart rate 
like [running orfootball, ] for at least 10 minutes continuously: 
(yes/no) 
 
35. In a typical week, on how many days do you do vigorous-intensity 
sports, fitness or recreational (leisure) activities::______ no. of days 
 
 
36.How much time do you spend doing vigorous-intensity 
sports, fitness or recreational activities on a typical day? 
______(hrs:mins) 
 
37. Do you do any moderate-intensity sports, fitness 
orrecreational(leisure) activities that causes a smallincrease in 
breathing or heart rate such as briskwalking,(cycling, swimming, 
volleyball)for at least 10 
minutes continuously? :  (yes/no) 
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38 In a typical week, on how many days do you do moderate-
intensity sports, fitness or recreational(leisure) activities? 
____________Number of days 
 
39.How much time do you spend doing moderate-intensity sports, 
fitness or recreational (leisure) activities on a typical day? 
________(hrs: mins) 
 
40.How much time do you usually spend sitting or reclining on a 
typical day? 
         Hours: minutes_______:________ 
 
Equivalent activites: 
Moderate intensity Vigorous intensity 
Walking briskly 
Bicycling (slower than 10 miles per 
hour) 
Water aerobics tennis doubles 
General gardening 
Race walking, 
 running, jogging, 
heavy gardening, hiking uphill 
Swimming,  
Tennis singles 
Bicycling faster than 10 miles per 
hour. 
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Annexure 3  
Modified Kuppusamy scale for socioeconomic status (2012): 
Education: 
Professional/honours 7 
Graduation/ post graduation 6 
Inter/post high school diploma 5 
High school certificate 4 
Middle school 3 
Primary school 2 
illiterate 1 
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Occupation: 
Profession 10 
Semi profession 6 
Clerical/ shop owner/farmer 5 
Skilled labour 4 
Semi skilledlabour 3 
Unskilled labour 2 
unemployed 1 
 
Family income per month in rupees: 
>= 30,375 12 
15,188 - 30,374 10 
11,362 - 15,187 6 
7,594 – 11,361  4 
4,556 – 7,593  3 
1,521- 4,555 2 
<=1520 1 
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SCORE CLASSIFICATION CLASS 
26-29 I  
16-25 II  
11-15 III  
5-10 IV  
<5 V  
132 
 
Annexure 4 : 
Protocol followed for the 24 hour diet recall: 
Adapted from Texas A&M University and Iowa State University, 8/06 by: 
Candace Gabel, MS, RD, LD and Ellen Schuster MS, RD. 
 
1. Explain to the participant that you need to know only what she (he) 
actually ate.  She (he) should not feel embarrassed about any food, as there are no 
“good” or “bad” foods.  No one eats just the right foods all the time. 
2. Do not express in words or facial expressions either approval or 
disapproval of foods mentioned by the participant.  
3. Do not ask questions that would lead the participant to feel she (he) 
“should” have had a certain item and, thus say that they did.  
4. Use your Food Recall Kit to determine the amounts of foods consumed. 
5. Start with the most recent meal or snack that the participant consumed.  
Work backwards to cover all foods and beverage consumed in the last 24 hours or 
in a “typical day”.  Weekends and holidays are not typical days and recalls from 
these days may provide an inaccurate view of the participant‟s diet. 
6.  Quick List:  
Record the list of foods as the homemaker remembers them; portion sizes and 
preparation methods will be recorded in the next step.  This list of foods is termed 
the quick list.  To obtain this list of foods from the participant use the following 
types of probes to find what foods were eaten: 
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A. The first type of probing is related to time. 
Examples: 
“At what time was this?  Did you eat or drink anything before or after that?” 
“What did you have at that time?” 
“At what time did you go to bed?” 
B.  The second type of probe is related to the participant‟s activities. 
 Examples: 
“What did you do this morning?” 
“While you were working around the house, did you take a break to have 
something to eat or drink?” 
“Did you watch TV last night?  When you watched TV, did you eat anything?” 
“Did you have anything to drink with this?” 
C. The third type of probe tries to get more complete information about 
foods already reported. 
 Examples: 
 “Do you remember anything else that you ate or drank with this food?” 
 “What else did you have at this meal?” 
 “Was the (bread, vegetable) eaten plain or did you put something on it? 
 “Did you have anything in your coffee?” 
 “Did you have a second helping?” 
134 
 
 
7. Detailed Description:  
After you have recorded the participant‟s quick list, you can then complete the      
detailed description of foods consumed.  This will include recording preparation 
method, brand name, portion size, and the time the food or beverage was 
consumed.   To get more information on the amounts and the type of foods eaten 
use the following techniques: 
A. Determine if all of the food was eaten or if some food was left on the plate. 
B. Encourage the participant to describe foods as clearly as possible.  The 
interviewer may have to restate questions to get more information.  
C. Describe combination dishes carefully.  Mixtures such as sandwiches, 
soups, stew, pizza, casseroles, etc. can be prepared in many ways.  
D. Ask to see packages, if available, on prepackaged foods, and record brand 
name and other pertinent information.  
8.  Review - Once the 24 hour food recall is complete read the list back to the 
participant.  Ask the participant if the recall is correct or if they forgot to mention 
any food was consumed 
9.  Thank the participant for their cooperation.  Do not comment on the recall 
atthis time, unless the participant asks a specific question.   
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10. Tell the participant that they will be getting a printout of their food recalland a 
summary of how their food intake meets USDA‟s MyPyramid recommendations. 
11.  Wait and address deficiencies, excesses, etc. when the diet summary is  
reviewed and when  lessons are taught that deal with that area of the diet. 
12.  Give each participant a copy of “What Should I Eat.”  
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Annexure 5:  
Dietary guidelines for Indians, National Institute of Nutrition, Hyderabad 
Approximate caloric value of fruits and nuts 
 
 Portion Calories 
Nuts   
Almonds 10 Nos. 85 
Cashewnuts 10 Nos. 95 
Coconut (fresh) 100 g 444 
Coconut (dry) 100 g 662 
Peanuts 50 Nos. 90 
Fresh  fruits  
Apple 1 medium 65 
Banana 1 medium 90 
Grapes 30 Nos. 70 
Guava 1 medium 50 
Jackfruit 4 pieces 90 
Mango 1 medium 180 
Mosambi/orange 1 medium 40 
Papaya 1 piece 80 
Pineapple 1 piece 50 
Sapota 1 medium 80 
Custard apple 1 medium 130 
Watermelon/muskmelon 1 slice 15 
Salads  
Beetroot 1 medium 30 
Carrot 1 medium 70 
Cucumber 1 medium 12 
Onion 1 medium 25 
Radish 1 medium 10 
Tomato 1 medium 10 
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Low  calorie  vegetables  and  fruits  (  20  kcal) 
 
 
 
 
 
 
 
 
 
 Name  of  the  vegetables Kcal 
   
 GLV  
   
 Amaranth (stem) 19 
   
 Ambat chukka 15 
   
 Celery stalk 18 
   
 Ipomoea stem 19 
   
 Spinach stalk 20 
   
 Roots  and  tubers  
   
 Radish table 16 
   
 Radish white 17 
   
 Other  vegetables  
   
 Ash gourd 10 
   
 Bottle gourd 12 
   
 Cluster beans 16 
   
 Colocasia stem 18 
   
 Cucumber 13 
   
 Ghosala 18 
   
 Kovai 18 
   
 Parwal 20 
   
 Ridge guard 17 
   
 Snake guard 18 
   
 Vegetable marrow 17 
   
 Fruits  
   
 Bilimbi 19 
   
 Jamb safed 19 
   
 Musk melon 17 
   
 Water melon 16 
   
 Orange juice 9 
   
 Tomato ripe 20 
   
Source:  Nutritive Value of Indian Foods, 2006  
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Vegetables  and  Fruits  with  High  calorie  value  (>  100kcal) 
  
Food  Stuff Kcal/100g 
  
Leafy  vegetables  
  
Chekkurmanis 103 
  
Colocasia leaves (dried) 277 
  
Curry leaves 108 
  
Fetid cassia (dried) (Chakunda) 292 
  
Rape leaves (dried) 297 
  
Tamarind leaves 115 
  
Roots  &  Tubers  
  
Arrow root flour 334 
  
Parsnip 101 
  
Sweet potato 120 
  
Tapioca 157 
  
Yam ordinary 111 
  
Yam wild 110 
  
Other  vegetables  
  
Beans, scarlet runner 158 
  
Jack fruit, seeds 133 
  
Karonda (dry) 364 
  
Lotus stem (dry) 234 
  
Sundakai (dry) 269 
  
Water chestnut (fresh) 115 
  
Water chestnut (dry) 330 
  
Fruits  
  
Apricot (dry) 306 
  
Avacado pear 215 
  
Banana 116 
  
Bael fruit 116 
  
Currants, red 316 
  
Dates (dried) 317 
  
Dates fresh 144 
  
Mahua (ripe) 111 
  
Raisins 308 
  
Seetaphal 104 
  
Wood apple 134 
  
Source:  Nutritive Value of Indian Foods, 2006  
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Approximate  Calorific  Value  of  Some  Cooked  Preparations 
 
 
Preparation Quantity  for  one  serving Calories 
   (Kcal) 
1. Cereal  
 Rice 1 cup 170 
 Phulka 1 No. 80 
 Paratha 1 No. 150 
 Puri 1 No. 80 
 Bread 2 slices 170 
 Poha 1 cup 270 
 Upma 1 cup 270 
 Idli 2 Nos. 150 
 Dosa 1 No. 125 
 Kichidi 1 cup 200 
 Wheat porridge 1 cup 220 
 Semolina porridge 1 cup 220 
 Cereal flakes with milk 
(corn/wheat/rice) 
1 cup 220 
 
2. Pulse   
 Plain dhal ½ cup 100 
 Sambar 1 cup 110 
3. Vegetable   
 With gravy 1 cup 170 
 Dry 1 cup 150 
4. Non-Vegetarian   
 Boiled egg 1 No. 90 
 Ommelette 1 No. 160 
 Fried egg 1 No. 160 
 Mutton curry ¾ cup 260 
 Chicken curry ¾ cup 240 
 Fish fried 2 big pieces 190 
 Fish cutlet 2 Nos. 190 
 Prawn curry ¾ cup 220 
 Keemakofta curry ¾ cup 240 
  (6 small koftas)  
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Approximate  Calorific  Value  of  Some  Cooked  Preparations 
 
 
 
Preparation Quantity  for  one  serving Calories  
 
   (Kcal) 
 
5. Savoury  snacks   
 
 Bajji or pakora 8 Nos. 280 
 
 Besankapura 1 No. 220 
 
 Chat (Dahi-pakori) 5 pieces 220 
 
 Cheese balls 2 Nos. 250 
 
 Dahivada 2 Nos. 180 
 
 Vada 2 Nos. 140 
 
 Masala vada 2 Nos. 150 
 
 Masala dosa 1 No. 200 
 
 Pea-kachori 2 Nos. 380 
 
 Potato bonda 2 Nos. 200 
 
 Sago vada 2 Nos. 210 
 
 Samosa 1 No. 200 
 
 Sandwiches (butter - 2tbsp) 2 Nos. 200 
 
 Vegetable puff 1 No. 200 
 
 Pizza (Cheese and tomato) 1 slice 200 
 
6. Chutneys   
 
 Coconut/groundnuts/til 2 tbsp 120 
 
 Tomato 1 tbsp 10 
 
 Tamarind 
(with jaggery) 1 tbsp 60 
 
 
 
7. Sweets  and  Desserts   
 
 Besanbarfi 2 small pieces 400 
 
 Chikki 2 pieces 290 
 
 Fruit cake 1 piece 270 
 
 Rice puttu ½ cup 280 
 
 Sandesh 2 Nos. 140 
 
 Double kameetha ½ cup 280 
 
 Halwa (kesari) ½ cup 320 
 
 Jelly/Jam 1 tbsp 20 
 
 Custard (caramel) ½ cup 160 
 
 Srikhand ½ cup 380 
 
 Milk chocolate 25 g 140 
 
 Ice-cream ½ cup 200 
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Preparation Quantity  for  one  serving Calories(Kcal)   
 
8. Beverages    
 
 Tea (2 tsp sugar + 1 cup 75 
 
  50 ml toned milk)   
 
 Coffee (2 tsp sugar + 1 cup 110 
 
  100 ml)   
 
 Cow's milk (2 tsp sugar) 1 cup 180 
 
 Buffalo's milk (2 tsp sugar) 1 cup 320 
 
 Lassi (2 tsp sugar) 1 cup/glass (200 ml) 110 
 
 Squash  1 cup/glass 75 
 
 Syrups (Sharabats) 1 cup/glass 200 
 
 Cold drinks 1 bottle (200 ml) 150 
 
 Fresh lime juice 1 glass 60 
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Annexure 6: 
Global Physical Activity questionnaire: 
 
CORE:   Physical  Activity 
 
Next I am going to ask you about the time you spend doing different types of physical activity in a typical week. Please 
answer these questions even if you do not consider yourself to be a physically active person.  
Think first about the time you spend doing work. Think of work as the things that you have to do such as paid or unpaid work, study/training, household chores, 
harvesting food/crops, fishing or hunting for food, seeking employment. [Insert other examples if needed]. In answering the following questions 'vigorous-intensity 
activities' are activities that require hard physical effort and cause large increases in breathing or heart rate, 'moderate-intensity activities' are activities that 
require moderate physical effort and cause small increases in breathing or heart rate.  
Read this opening statement out loud. It should not be omitted. The respondent will have to think first about the time he/she spends doing work (paid or unpaid work, household chores, 
harvesting food, fishing or hunting for food, seeking employment [Insert other examples if needed]), then about the time he/she travels from place to place, and finally about the time spent 
in vigorous as well as moderate physical activity during leisure time.  
Remind the respondent when he/she answers the following questions that 'vigorous-intensity activities' are activities that require hard physical effort and cause large increases in breathing or 
heart rate, 'moderate-intensity activities' are activities that require moderate physical effort and cause small increases in breathing or heart rate. Don't forget to use the showcard which will help 
the respondent when answering to the questions. 
Question Response  Code 
 
        
 Does  your  work  involve vigorous-intensity  activity  that      
 
 causes  large increases  in breathing or heart  rate like Yes 1     
 
[carrying  or lifting  heavy  loads,  digging  or construction           
 
52 work]for  at  least  10  minutes  continuously?     P1  
      
 Activities  are  regarded  as  vigorous  intensity  if  they      
 
 cause  a  large  increase  in  breathing  and/or  heart  rate. No 2 If  No,  go  to  P  4   
       
 [INSERT  EXAMPLES]   (USE  SHOWCARD)      
 
 In a typical  week,  on  how  many  days  do you do      
 
 vigorous-intensity  activities  as  part  of  your work? 
Number of  days 
    
 
53 “Typical  week” means  a  week  when  a  person  is  doing 
   
P2       
      
 vigorous  intensity  activities  and  not  an  average  over  a  
 
  
 
 period.     Valid  responses  range  from  1-7.     
       
 How much time do you spend  doing  vigorous-intensity      
 
 activities  at  work  on a typical  day?     
P3 
 
54 Think  of  one  day  you  can  recall  easily.  Consider only 
    
 
Hours  :  minutes    (a-b) 
 
those  activities  undertaken  continuously  for 10  minutes          
     or more.   Probe  very  high  responses  (over 4  hrs)  to    
       
 verify.   hrs mins  
 
 Does  your  work  involve moderate-intensity  activity,  that      
 
 causes  small  increases  in breathing  or heart  rate such Yes 1     
 
as  brisk  walking [or carrying  light  loads]  for at  least  10 
    
      
 
55 minutes  continuously?     P4  
      
 Activities  are  regarded  as  moderate  intensity  if  they      
 
 cause  a  small   increase  in  breathing  and/or  heart  rate. No 2 If  No,  go  to  P  7  
 
 [INSERT  EXAMPLES]     (USE  SHOWCARD)      
 
 In a typical  week,  on  how  many  days  do you do      
 
56 moderate-intensity  activities  as  part  of  your work? Number of  days    P5  
     
 Valid  responses  range  from  1-7     
 
        
 How much time do you spend  doing  moderate-intensity      
 
 activities  at  work  on a typical  day?     
P6 
 
57 Think  of  one  day  you  can  recall  easily.  Consider only 
    
 
Hours  :  minutes    (a-b) 
 
those  activities  undertaken  continuously  for 10  minutes          
  
   or more.   Probe  very  high  responses  (over 4  hrs)  to    
       
 verify.   hrs mins  
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Travel  to  and  from  places      
  
The  next  questions  exclude  the  physical  activities  at  work  that  you  have  already  mentioned.  
Now I would like to ask you about the usual way you travel to and from places. For example to work, for shopping, 
to market, to place of worship. [insert other examples if needed]  
The introductory statement to the following questions on transport-related physical activity is very important. It asks and helps the participant to now 
think about how they travel around getting from place-to-place. This statement should not be omitted.  
 Do you walk  or use a  bicycle (pedal  cycle) for at  least Yes 1    
 
10 minutes  continuously  to get  to  and  from places? 
 
P7 
 
58     
     
 Circle  the  appropriate  response. No 2 If  No,  go  to  P  10   
      
       
 In a typical  week,  on  how  many  days  do you walk  or    
P8 
 
59 bicycle for at  least  10 minutes  continuously  to get  to Number of  days    
      
 and from places? Valid  responses  range  from  1-7    
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WHO  STEPwise approach to chronic  disease risk  factor surveillance- Instrument  v2.1 5-2-8 
 
 Participant  Identification  Number   
 
      
 
 How much time do you spend  walking or bicycling for     
 
 travel  on a typical  day?    
P9 
 
60 Think  of  one  day  you  can  recall  easily.  Consider the Hours  :  minutes 
  
 
  
(a-b) 
 
total  amount  of  time  walking  or  bicycling  for  trips  of  10 
   
    
  
   minutes  or  more.   Probe  very  high  responses  (over  4    
      
 hrs) to  verify.  hrs mins  
 
Recreational  activities     
 
     
The  next  questions  exclude  the  work  and  transport  activities  that  you  have  already  mentioned.    
 
Now  I  would  like  to  ask  you  about  sports,  fitness  and  recreational  activities  (leisure),[insert  relevant  terms ].  
 
This  introductory  statement  directs  the  participant  to  think  about  recreational  activities.  This  can  also  be  called   discretionary  or  leisure  time.  It  includes  sports 
  
and exercise but is not limited to participation competitions. Activities reported should be done regularly and not just occasionally. It is important to focus on only 
recreational activities and not to include any activities already mentioned. This statement should not be omitted. 
Question Response  Code 
 
        
 Do you do  any  vigorous-intensity  sports,  fitness  or      
 
 recreational  (leisure) activities  that  cause large Yes 1     
 
increases  in breathing or heart  rate like [running  or 
    
      
 
61 football,  ]  for at  least  10 minutes  continuously?     P10  
      
 Activities  are  regarded  as  vigorous  intensity  if  they      
 
 cause  a  large  increase  in  breathing  and/or  heart  rate. No 2 If  No,  go to  P  13  
 
 [INSERT  EXAMPLES]     (USE  SHOWCARD)      
 
 In a typical  week,  on  how  many  days  do you do     
P11 
 
62 vigorous-intensity  sports,  fitness  or  recreational Number of  days     
       
 (leisure) activities? Valid  responses  range  from  1-7.     
 
        
 How much time do you spend  doing   vigorous-intensity      
 
 sports,  fitness  or  recreational  activities  on a typical  day?     
P12 
 
63 Think  of  one  day  you  can  recall  easily.  Consider the 
    
 
Hours  :  minutes    (a-b) 
 
total  amount  of  time  doing  vigorous  recreational          
  
   activities  for periods  of  10  minutes  or  more.   Probe  very    
       
 high  responses  (over  4  hrs).   hrs mins  
 
 Do you do  any  moderate-intensity  sports,  fitness  or      
 
 recreational  (leisure) activities  that  causes  a small 
Yes 1 
   
 
 increase in breathing or heart  rate such as  brisk           
 
64 
walking,(cycling,  swimming,  volleyball)for at  least  10     
P13 
 
minutes  continuously?      
       
 Activities  are  regarded  as  moderate  intensity  if  they 
No 2 If  No,  go  to  P16 
 
 
 cause  a  small   increase  in  breathing  and/or  heart  rate.   
       
 [INSERT  EXAMPLES]     (USE  SHOWCARD)      
 
 In a typical  week,  on  how  many  days  do you do      
 
65 
moderate-intensity  sports,  fitness  or  recreational 
Number of  days 
   
P14  
(leisure) activities?           
       
 Valid  responses  range  from  1-7      
       
 How much time do you spend  doing  moderate-intensity      
 
 sports,  fitness  or  recreational  (leisure) activities  on a      
 
 typical  day?     P15  
66 Think  of  one  day  you  can  recall  easily.  Consider the 
    
 
Hours  :  minutes    (a-b)       
 
total  amount  of  time  doing  moderate  recreational        
 
 
 
 activities  for periods  of  10  minutes  or  more.   Probe  very    
       
 high  responses  (over  4  hrs).   hrs mins  
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EXPANDED:  Physical  Activity 
 
Sedentary  behavior 
 
The following question is about sitting or reclining at work, at home, getting to and from places, or with friends including time spent sitting at a desk, sitting with 
friends, traveling in car, bus, train, reading, playing cards or watching television, but do not include time spent sleeping. 
[INSERT  EXAMPLES]     (USE  SHOWCARD) 
 How much time do you usually  spend  sitting or reclining    
 
 on a typical  day?   
P16 
 
67 Consider total  time  spent  at  work  sitting,  in  an  office, 
  
 
Hours  :  minutes  (a-b) 
 
reading,  watching  television,  using  a  computer,  doing      
 
   hand  craft  like  knitting,  resting  etc.  Do  not  include  time   
     
 spent  sleeping. hrs min s  
 

